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Antibodies generated by B cells neutralize pathogens and pathogen-secreted toxins 
and flag them for immune clearance. Antibody responses are initiated via binding of 
cognate antigen to B-cell receptors (BCR). This induces BCR aggregation in lipid 
rafts, promoting BCR signaling and internalization of antigen for processing and 
presentation to T helper cells, which is essential for generating high affinity and long-
lasting antibody responses. The ability of an immunogen to activate BCR signaling 
and internalization is necessary for efficient vaccines. To capture these immunogens, 
B cells circulate and migrate through blood and lymphoid tissues. During circulation, 
the plasma membrane of B cells may be damaged by mechanical forces and 
membrane-perforating toxins. The impact of plasma membrane damage on B-cell 
activation is unknown.  
The first part of this thesis investigated the mechanism of plasma membrane 
repair in B cells and the effects of repair on BCR activation. My research reveals that 
  
B cells rapidly repair membrane wounds provoked by streptolysin O, a pore forming 
bacterial toxin. Similar to the mechanism reported for fibroblasts and muscle cells, B 
cells repair by Ca2+ triggered lysosome exocytosis, which releases acid 
sphingomyelinase (ASM) to the plasma membrane to induce endocytosis of damaged 
membrane. Different from previous reports, ASM induces direct endocytosis of lipid 
rafts in the absence of the membrane invaginating lipid raft protein, caveolin. 
Importantly, it was discovered that BCR activation interferes with plasma membrane 
repair, while wounding inhibits BCR signaling and internalization by segregating 
BCRs from lipid rafts. These data suggest that plasma membrane repair and B cell 
activation interfere with one another due to competition for lipid rafts.   
The second part of my thesis established and characterized a membrane-bound 
antigen system where all antigenic molecules are optimally oriented for BCR binding. 
Using the new system, we investigated the role of the density and valency of 
membrane-bound antigen on BCR activation. The results show that increases in the 
density but not valency of antigen on membranes significantly enhance the 
magnitudes of the early events of BCR activation, including BCR self-clustering, cell 
spreading on antigen-presenting surface, and protein tyrosine phosphorylation. The 
enhanced signaling is correlated with greater actin dynamics required for BCR 
aggregation, B-cell spreading and signaling. These results indicate that this model 
antigen will benefit quantitative studies of the molecular mechanisms underlying 
BCR activation, and also suggest that manipulations of molecular configuration and 
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Chapter 1: Introduction 
1.1 Innate and adaptive immunity 
The vertebrate immune system is divided into two branches that protect the host from 
pathogens: the innate immunity and adaptive immunity. The innate immune response 
is the first line of defense against invading microbes and mediated by immune cells 
like neutrophils and macrophages. The activation of the innate immune responses 
depends on surface and internal receptors that recognize pathogen-associated 
molecular patterns (PAMPs) or host derived damage-associated molecular patterns 
(DAMPs) (1, 2). PAMPs such as lipoproteins and glycolipids present on bacterial 
surfaces or double stranded RNA made by viruses are recognized by pattern 
recognition receptors (PRRs), including Toll-like receptors (TLR), RIG-I like 
receptors, and Nod-like receptors (NLR) (1-4). The binding of PRRs to their 
respective PAMPs induces signaling, which leads to the production and secretion of 
cytokines that affect the development and activation of leukocytes belonging to the 
adaptive immune response (3-5). The adaptive immune response has two major 
players, B lymphocytes (B cells) and T lymphocytes (T cells). Unlike the innate 
immunity, the induction of adaptive immune responses relies on distinct receptors 
highly specific for antigens. This specificity comes from the rearrangement of the 
variable (V), diversity (D), and joining (J) gene segments of the B cell receptor 
(BCR) or T cell receptor (TCR) during development, giving rise to clonally varient 
lymphocytes. Another major difference between the adaptive and  innate immunity is 




response and effector functions are immediate and more robust with a repeated 
encounter of the same antigen(6, 7). 
Adaptive immunity is divided into two branches, humoral immunity that is 
antibody-mediated by B cells, and cellular immunity that is mediated by T cells. 
BCRs recognize antigens in their native conformational form and can bind antigens in 
any chemical and physical form. B cells produce antibodies; this neutralizes 
pathogens or toxins and opsonizes them for elimination via phagocytic cells by 
binding to them with high specificity (6, 8). T cells do not recognize antigens in their 
native form as B cells do; they only recognize antigens (peptides and 
polysaccharides) that have been processed and presented on the surfaces of cells. 
Cytotoxic T cells (CD8+ T cells) recognize antigens bound to major 
histocompatibility complex class I molecules (MHCI) on the surfaces of all nucleated 
cells and destroy any cells presenting foreign antigens. Helper T cells (CD4+ T cells) 
recognize antigens loaded on major histocompatibility complex class II molecules 
(MHCII) and release cytokines for stimulation of various leukocytes. MHCII is only 
expressed by professional antigen-presenting cells (APCs), like macrophages, 
dendritic cells, and B cells. Antigen-presenting cells internalize antigen bound to their 
receptors, degrade and load them onto MHCII for exocytosis to cell surfaces for 
interaction with helper T cells (6, 9, 10).  
1.2 Development and maturation of B cells 
B cells develop from hematopoietic precursors in the bone marrow. Here they first 
start out as progenitor B cells (Pro-B cells), expressing surface pro-BCRs, consisting 




progress into Pre-B cells after Recombination-activating gene (Rag)-mediated 
variable (V), diversity (D), and joining (J) gene rearrangement of the heavy µ chain. 
The heavy chains of IgM are expressed as membrane bound forms (mIgM) in 
association with surrogate light chains (λ5 and VpreB) and the Igα/Igβ heterodimer 
to generate the Pre-BCR. Igα/Igβ is the signaling transduction unit of the Pre-BCR 
and mature BCR by conveying signals from the BCR to cytoplasmic signaling 
molecules. Signaling though the Pre-BCR is important for transition into immature B 
cells, that are denoted by expression of mature BCRs, which have replaced the 
surrogate light chains of pre-BCR for successfully VJ rearranged light chains (κ and 
λ) (7, 11-13). In the bone marrow, immature B cells go through checkpoints to 
eliminate self-reactive B cells. B cells expressing BCR with high affinity binding to 
self-antigens are deleted by signaling-induced apoptosis, whereas low affinity binding 
results in Ig gene  editing (further rearrangement of Ig gene) or anergy (unresponsive 
to antigen) (14, 15).  
After successful production of non-self reacting BCRs, the immature B cells 
leave the bone marrow and enter the secondary lymphoid organs, where they become 
transitional B cells of type 1 (T1) expressing high lvels of  IgM and CD93. T1 cells 
migrate to B cell follicles to develop into transitional B cells of type 2 (T2) and begin 
to express IgD, Fc receptors for IgE (CD23), and complement receptor (CD21). 
These T2 cells then become mature B cells, which lose CD93 expression and 
decrease IgM expression. Mature B cells circulate through the spleen or lymph nodes 





Naïve (have not encountered antigen) mature B cells are subdivided into B1 
and B2 categories. B1 cells include B1a and B1b cells that are located within the 
pleural and peritoneal cavities. B1 cells are responsible for generating innate-like 
antibody responses. Their activation relies on innate signals like TLRs and is 
independent of T helper cells. B1 B cells mount IgM and IgA antibody responses 
against non-protein antigens. Such antibody responses are generated without any 
prior antigen challenge, thereby categorized as natural antibodies (19-21). B2 cells 
have several subsets including marginal zone (MZ), follicular (FO), and germinal 
center (GC) B cells. MZ B cells share many properties with B1 cells. They express 
various TLRs and rapidly produce IgM antibodies to TI antigens. MZ B cells reside 
within the marginal zone of the secondary lymphoid tissues, like the spleen, where 
they are given access to blood circulating through the lymphoid organs and hence 
sample for blood-borne pathogens (21, 22). Recent studies show that MZ B cells as 
well as MZ macrophages are capable of transporting antigens into B cell follicules 
where MZ B cells can present antigen to FO B cells directly or indirectly via 
follicular dendritic cells (23).  
B cell activation requires two signals. Antigen binding induces signaling as 
the first signal for B cell activation. Subsequently, B cells internalize and process 
antigen as MHC II complexes for the recognition of T helper cells. Interactions of T 
cells with peptide-loaded MHC II complexes induce T cell activation.  Activated T 
cells provide the second signal for B cell activation, including CD40 ligand to bind to 
CD40 on the B cell surface and cytokines. After receiving both signals from BCR 













Fig. 1.2: B cell development and maturation. B cell development begins in the 
bone marrow from hematopoietic precursors. The progenitor B cell (Pro-B cell) 
produces the Pro-BCR, consisting of calnexin and the signaling transduction 
heterodimer, Iga and Igb. Expression of the Pre-BCR consisting of rearranged IgM 
heavy chains and surrogate light chains (VpreB and Vλ5) leads to the development of 
Pre-B cells. Signaling through the Pre-BCR induces development into the immature B 
cell, which expresses rearranged IgM heavy chain and light chains (κ and λ) as 
membrane IgM-based BCR. Immature B cells migrate from the bone marrow to the 
secondary lymphoid organs where they differentiate into transitional B cells of type 1 
(T1) and express IgM and CD93. In the B cell follicles, T1 B cells develop into 
transitional B cells of type 2 (T2) that gain the expression of CD23 and CD21. T2 B 
cells become mature B cells that lose expression of CD93 and decrease expression of 
IgM, while increasing expression of IgD. In the secondary lymphoid organs, mature 
B cells may encounter their cognate antigen, which activates signaling, and antigen 
processing and presentation for the recognition of helper T cells. B cell signaling and 
T cell help enable B cells to differentiation into antibody secreting plasma cells or 










the differentiation of B cells into short-lived plasma cells and the development of 
germinal center precursors (24, 25). The germinal centers are largely divided into a 
dark zone and a light zone. The dark zone is made up of rapidly proliferating B cells, 
while the light zone contains T cells and follicular dendritic cells. In the germinal 
center, B cells migrate from the dark zone to the light zone to interact with T cells and 
antigen presented by follicular dendritic cells, which enables isotype switching and 
affinity maturation of B cells. The variable gene region of Ig genes undergoes somatic 
hypermutation. Only the B cells expressing BCRs with enhanced affinity to antigen 
gain survival and differentiation signals from BCR signaling and T helper cells via 
antigen processing and presentation. These signals enable B cells to differentiate into 
either long-lived plasma cells or memory B cells (24, 26, 27). Long-lived plasma cells 
migrate to the bone marrow, which provides specialized niches for their survival. In 
the bone marrow, long-lived plasma cells maintain the level of antibodies, offering 
extended protection to the host (28, 29). Memory B cells are capable of self-renewal 
and circulate though lymphoid organs, where they remain as resting cells until 
stimulated by antigen. Upon activation, they undergo rapid clonal expansion and give 
rise to plasma cells that secrete high affinity antibody to quickly combat the pathogen, 
which is characteristic of secondary immune responses provided by the adaptive 
immunity (30, 31). 
 
1.3 B cell-mediated antibody responses 
Immunoglobulins (Ig) or antibodies are glycoproteins that are essentially the secreted 




covalently associated Igα/β. They consist of paired heavy and light chains. The 
structure analysis show that antibody appears as a Y-shape, where the arms of the Y, 
or F(ab’)2 fragment, contains the variable regions that binds to antigen, and the stem 
of the Y, or Fc fragment, interacts with effector molecules, such as complement, or Fc 
receptors on cells, like macrophages, to induce phagocytosis of the antibody bound 
antigen (Fig. 1.3). There are five Ig isotypes, which vary in their Fc fragments and 
functions: IgM, IgD, IgG, IgA, and IgE. IgM and IgG circulate in the blood and play 
a major role in opsonization and complement activation, IgA is important for 
neutralization of pathogens on mucosal surfaces, and IgE is involved in allergic 
reactions by activating mast cells (32). 
There are two ways that B cells may become stimulated and produce 
antibodies: T cell dependent (TD) or T cell independent (TI) activation. For TD 
activation, a B cell must internalize, process, and present antigen peptides or 
polysaccharides bound to MHCII to helper T cells. Via antigen presentation, both T 
and B cells become stimulated, and activated T cells release cytokines that induce B-
cell proliferation, antibody production, and memory B cell development. With  T cell 
help  through  CD40 and release of cytokines, B cells undergo affinity maturation in 
the germinal center where the variable region of Ig genes undergo hypermutation 
isotype switching, affinity maturation, and differentiation into antibody producing 




 Fig. 1.3:  Basic structure of the antibody. Antibodies are the secreted form of the B 
cell receptor (BCR). They consist of two identical heavy chains held together by 
disulfide bonds and two identical light chains held to each of the heavy chains 
through disulfide bonds. The N-terminus of the heavy and light chains contains the 
variable regions (VL and VH) that form two antigen binding sites. The Fc region of 
antibodies is glycosylated and consist of a number of constant regions formed by a 
pair of the heavy and light chains (CH1) or a pair of the heavy  on the C-terminus side 
(CH2 and CH3). The Fab fragment is monovalent and consists of one light chain and 
its corresponding heavy chain section (CH1 and VH). The F(ab’)2 fragment is divalent 







B cells with enhanced binding affinity to antigen, while isotype switching is 
important for antibody effector functions. Naïve B cells only express IgM and IgD 
immunoglobulin on their surfaces. In response to antigenic stimulation and T cell 
help, the gene encoding the constant regions of IgM and IgD heavy chain are 
switched to IgG, IgA, or IgE, depending on the type of cytokine directing the B cell. 
Interleukin 4 (IL-4) induces IgG1 and IgE switching, while interferon-γ (INF-γ) 
decreases IgG1 and increases IgG2 production. IgA generation is enhanced by 
transforming growth factor β (TGF-β), IL-2, and IL-5 (10, 33-35).   
TI activation differs from TD in that it does not require T cell help to produce 
antibodies; however, TI response is predominately IgM production, lacking affinity 
maturation and long lasting memory (36, 37). TI antigens are generally 
polysaccharides and are divided into two types, TI type 1 (TI-1) and TI type 2 (TI-2) 
antigens. TI-1 antigens, such as lipopolysaccharides (LPS), induce polyclonal B cell 
proliferation. TI-2 antigens, like capsular polysaccharides (PS) from bacterial 
pathogens, including Neisseria meningitidis, Haemophilus influenza or Streptococcus 
pneumonia, contain multiple repeating antigenic structures that extensively cross-link 
BCRs and strongly activate receptors (36-38). It has been suggested that TI-2 
stimulation leads to B cell differentiation into long-lived plasma cells (PC) that 
secrete IgM or memory PCs. Differentiation of B cells into these memory PCs 
requires a second signal, such as stimulation through TLRs and cytokines (21, 38). B 
cells express TLRs, including TLR1–TLR2, TLR4, TLR6, TLR7 and TLR9; and it is 
known that stimulation through TLRs can lead to B cell proliferation and antibody 




and marginal zone (MZ) B cells having elevated responses to TLR stimulation 
compared to follicular (FO) B cells, which depend less on TLR activation and mostly 
on T helper stimulation. B-1 and MZ B cells are a part of the innate immunity, as they 
can rapidly produce antibody to TI antigen. Although the antibodies they produce are 
typically low affinity IgM, the antibodies are nonetheless important in combating 
bacterial pathogens, such as Streptococcus pneumonia (21, 39).  
 
1.4 B cell receptors and signaling 
Activation of the B cell begins with recognition of antigen by B cell receptors 
(BCRs). BCRs then self-aggregate for initiating signaling. The BCR comprises of a 
membrane immunoglobulin (mIg) that is non-covalently associated with a 
heterodimer of Igα (CD79a) and Igβ (CD79b). Igα and Igβ are held together by a 
disulfide bond. The mIg binds antigen and Igα/Igβ are transmembrane proteins 
responsible for signal transduction. Both Igα and Igβ contain immunoreceptor 
tyrosine-based activation motifs (ITAMs) in their cytoplasmic tails (Fig. 1.4). When 
BCRs are cross-linked by antigen, they become associated with lipid rafts (cholesterol 
and sphingolipid enriched membrane microdomains) and come into contact with lipid 
raft-resident protein tyrosine kinases (PTKs), particularly Src-family kinases, 
including Lyn and Fyn, which phosphorylate the ITAMs in Igα/Igβ (40-44). ITAMs 









Fig. 1.4: BCR signaling pathways. BCRs aggregated by binding to their cognate 
antigen initiate signal transduction through the phosphorylation of the 
immunoreceptor tyrosine-based activation motifs (ITAM) in the cytoplasmic tails of 
Igα and Igβ. This creates docking sites for spleen tyrosine kinase (Syk), which is then 
activated by Lyn. Syk activates Bruton’s tyrosine kinase (Btk) that associates with B 
cell linker protein (BLNK), an adaptor molecule that interacts with Vav, Grb2, and 
phospholipase-Cγ2 (PLCγ2). Vav activates Rac, leading to signaling through the Rac-
MAPK pathway and phosphorylation of p38 and JNK. Grb2, an adaptor protein, 
binds SOS that associates with Ras to initiate the Ras-MAPK family pathway that 
leads to activation of Erk. PLCγ2 cleaves phosphatidylinositol-4,5-bisphosphate 
(PIP2)  into diacylglycerol (DAG) and inositol triphosphate (IP3).  IP3 induces 
calcium release from the ER and eventual activation of the transcription factor, 
NFAT, and DAG and calcium activate protein kinase C (PKC), leading to activation 
of the transcription factor, NF-kB. The activated transcription factors from the 
signaling pathways promote expression of molecules involved in B cell development, 






 containing tyrosine kinase, spleen tyrosine kinase (Syk). Syk is vital in BCR-
mediated signaling and activates many downstream signaling molecules in 
signalosomes at the plasma membrane. Syk phosphorylates Bruton’s tyrosine kinase 
(Btk), which is recruited to the cell surface by binding to phosphatidylinositol-3,4,5-
triphosphate (PIP3 ) via its pleckstrin homology (PH) domain and B cell linker protein 
(BLNK). BLNK is a key adaptor molecule, serving as a scalfold for the signalosome. 
Phosphorylated by Syk, BLNK recruits many signaling molecules to signalosomes, 
such as phospholipase-Cγ2 (PLCγ2), Vav, a guanine nucleotide exchange factor of 
Rho-family GTPases, and Grb2, an adaptor protein. Grb2 binds SOS, which activates 
Ras to initiate the Ras-MAPK family pathway. PLCγ2, activated by Syk and Btk, 
cleave phosphatidylinositol-4,5-bisphosphate ( PIP2)  into diacylglycerol (DAG) and 
inositol triphosphate (IP3). IP3 induces calcium release from the ER, and DAG and 
calcium activate protein kinase Cβ (PKCβ). Calcium flux leads to the activation of 
the transcription factor, NFAT, and PKCβ is involved in activating the transcription 
factor, NF-κB (42, 45-47). The transcription factors activated through the BCR-
mediated signaling pathways promote expression of molecules required for B cell 
development, survival, proliferation, and activation (48). 
BCR signaling events are positively or negatively controlled depending on the 
surface molecules recruited and activated within the vicinity of BCRs. CD19 is a 
stimulatory co-receptor complexed with the complement receptor CD21 and the 
tetraspanin protein CD81. CD19 is recruited to BCRs in response to antigenic 
stimulation and complement opsonized antigen. The CD19-CD21-CD81 complex 




and also prolongs BCR-mediated signaling (45, 49). Complement coated pathogens 
cross-link the BCR with the complement receptor, CD21, bringing the CD19-CD21-
CD81 complex in close proximity of the BCR, allowing CD19 to be phosphorylated 
and recruit phosphatidylinositol 3-kinase (PI3K) and Btk. CD19 recruitment of PI3K 
enhances calcium signaling by supplying the docking sites of Btk, PIP3 (45, 46). 
CD19 is important in B cell activation and mediating B cell effector functions, as 
mice that lack CD19 have significant reductions in B cell proliferation after mitogen 
stimulation, germinal center reactions, and serum antibody levels (50, 51). FcγRIIB is 
an inhibitory co-receptor of the BCR. The FcγRIIB is cross-linked with the BCR 
when B cells encounter antigen-antibody immune complexes, which leads to 
phosphorylation of the immunoreceptor tyrosine-based inhibition motif (ITIM) its 
cytoplasmic tail by Lyn. The phosphorylated ITIM of the cytoplasmic tail recruits the 
SH2-domain containing inositol 5’-phosphatase 1 (SHIP1). SHIP1 dephosphorylates 
5’ phosphate groups of PIP3, thus suppressing calcium signaling by preventing 
recruitment of Btk and PLCγ to the plasma membrane. FcγRIIB also recruits docking 
protein 1 (DOK-1) that down regulates Ras activation through recruitment of Ras 
GTPase-activating protein (GAP) (43, 52, 53). It has also been shown that FcγRIIB 
inhibits early B cell activation by preventing BCR clustering and thus reducing BCR-
mediated signaling (54). The negative control on BCR signaling by FcγRIIB is 
essential for normal B cell activation and function, preventing unregulated, over-
activation that can have detrimental outcomes. Functionally impaired FcγRIIB and its 
downstream SHIP-1 are associated with the development of autoimmune diseases, 





1.5 BCR and actin dynamics in B-cell activation 
In vivo, B cells encounter antigen either as soluble or membrane bound. The majority 
of antigen in B cell follicules is presented as the membrane bound form by antigen 
presenting cells (APCs), such as macrophages, follicular dendritic cells, dendritic 
cells, and marginal zone B cells, which bind oposonized antigens via complement and 
Fc receptors (23, 56). BCR and actin dynamics have been examined extensively using 
total internal reflection fluorescence microscopy (TIRFM). TIRFM allows for the B 
cell membrane to be imaged with high resolution at the interface of its attachment site 
to antigen presenting membranes, enabling detailed examination of BCR clustering, 
actin dynamics, and synapse formation. 
BCR recognition of membrane bound antigen induces BCR clustering and B 
cell spreading over the target membrane. This increases the B cell contact area with 
the target membrane and accumulates more antigens for BCR activation. During 
spreading, the number of BCR clusters increase at the leading edges of the spreading 
B cell membrane. These BCR clusters signal and begin merging at the center of the B 
cell contact area. After reaching its maximal spreading, the B cell then contracts, 
reducing its contact area with the target membrane. BCR clusters reduce in signaling 
and coalesce to the center of the B cell contact area to form the central BCR cluster 
(immunological synapse) (57-59) (Fig. 1.5).  
B cell spreading, BCR clustering, and immunological synapse formation 
require actin. This has been demonstrated using actin polymerization inhibitors or 




signaling and B cell activation (60-64). Upon BCR engagement, there is a transient 
depolymerization of cortical actin, allowing for free later diffusion of surface BCRs 
(60, 65, 66). The BCRs cluster and begin signaling, leading to actin polymerization 
and co-localization with BCR clusters (61, 67). As BCR clustering and signaling 
continues, the B cell spreads over the target membrane and actin is seen to be 
distributed along the leading edges of the spreading B cell membrane. When maximal 
spreading is reached and the B cell membrane contracts, actin is seen as a ring around 
BCRs, contracting BCR clusters to form the immunological synapse (Fig. 1.5) (61, 
64).  
The initiation of BCR clustering induced by membrane bound antigen is 
suggested to be due to a conformational change in the Cµ4 domain of the mIgM 
ectodomain. This conformational change exposes an interface that mediates BCR- 
BCR interaction and induces BCR acquisition of lipid rafts (68, 69). This enables 
BCRs to interact with lipid raft associated Lyn and commence signaling (44). Early 
BCR signaling induces a transient depolymerization of the cortical actin cytoskeleton, 
which enhances BCR clustering and signaling activity. 
The cortical actin cytoskeleton is attached to the plasma membrane through 
ezrin, a member of the Ezrin-Radixin-Moesin (ERM) family of proteins, which are 
actin binding proteins and attach F-actin to the plasma membrane by interacting with 
integral proteins. The cortical actin and ezrin networks have been shown to create 
diffusion boundaries on the plasma membrane, restricting the lateral movement of 








Fig. 1.5: BCR and actin dynamics in B cell activation.  
(A) Upon BCR engagement to membrane bound antigen, the cortical actin 
depolymerizes to allow clustering of BCRs, which initiates signaling and (B) 
reassembly of actin to mediate spreading over the membrane to capture more antigen, 
increase BCR clusters, and amplify BCR signaling. (C) Reaching maximal spreading, 
BCR clusters begin to decrease in signaling and actin initiates movement of the BCR 
clusters towards the center of the cell contact area to form the synapse. (D) After 
maximal spreading, the cell membrane contracts in an actin dependent manner, 
decreasing the cell contact area and pulling remaining BCR clusters into the synapse.  
 
Interference reflection microscopy (IRM) shows sites of close contact between a cell 
and substratum.  
Total internal reflection fluorescence microscopy (TIRFM) is used to visualize 
fluorophores present in the near-membrane region of live or fixed cells.  
 






bound antigen, surface BCRs increase lateral diffusion on the membrane surface. The 
disassembly of the cortical actin is induced by ezrin dephosphorylation, which causes 
the disassociation of ezrin from F-actin, consequently detaching the actin network 
from the plasma membrane. In addition, actin undergoes cofilin-dependent 
depolymerization (60, 65, 66, 70). Actin depolymerization also enables BCR clusters 
to interact with CD19 in lipid rafts (66). This interaction enhances BCR clustering, 
actin rearrangement, BCR signaling, and also B cell spreading on the antigen 
presenting membrane, which increases the number of BCRs engaging antigen and 
hence increases the BCR signaling amplification. The ability of the B cell to spread 
over target membranes and collect more antigen for increasing BCR activation is why 
membrane bound antigens have more potency than soluble antigen.  
BCR clusters that associate with CD19 in lipid rafts recruit signaling 
molecules, including Syk, Btk, BLNK, Vav, and PLCγ2. The recruitment and 
function of these signaling molecules have been demonstrated to be necessary in 
forming signaling BCR clusters (microsignalosomes) that are involved in continuing 
B cell spreading. Syk, Btk, Vav, and PLCγ2 have been shown to be required for B 
cell spreading, as signaling induces and enhances actin rearrangement (58, 63, 71). 
Btk activation leads to the activation of Wiskott–Aldrich symptom protein (WASP), 
an actin nucleation promoting factor (72, 73). Btk activates WASP via inducing the 
phosphorylation of Vav, a guanine-nucleotide exchange factor (GEF) for the Rho 
GTPases, Rac and Cdc42, and increasing the production of PI-4,5-P2  (74). As the B 
cell membrane continues spreading over the antigen presenting membrane, new BCR 




of the B cell contact zone show the strongest signaling, visualized by phosphotyrosine 
staining. Signaling BCR clusters on the outer edge are then pulled toward the center 
of the cell, where BCR clusters coalesce into the central BCR cluster and reduce 
signaling activity. When the B cell has reached its maximal spreading on the antigen 
presenting membrane, the B cell contracts its membrane in an actin-dependent 
manner. This decreases the B cell contact area with the target membrane and the 
remaining BCR clusters on the outer edges are pulled toward the center of the cell 
contact area, where F-actin forms a ring like structure surrounding the synapse (58, 
59, 61, 63, 64). 
The growth of the BCR/antigen clusters and formation of the immunological 
synapse is actin-dependent. Treatment of B cells with Latrunculin A immediately 
after the B cell has spread over antigen presenting membrane, inhibits antigen 
accumulation, BCR cluster signaling and movement into the synapse (60-62). The 
inhibitory molecule, SH2-domain containing inositol 5’ phosphatase 1 (SHIP1) has 
been shown to inhibit actin polymerization through suppression of Btk-dependent 
activation of WASP. Reducing the activation of WASP is necessary for B cell 
contraction, merging BCR clusters together into the synapse, and signaling 
attenuation (73). Previous work from my lab has demonstrated that Neuronal 
Wiskott–Aldrich syndrome protein (N-WASP) is required for B cell contraction and 
BCR signaling attenuation. Furthermore, N-WASP activation inhibits WASP 
activation (75). BCR central cluster formation and stability also require Rap GTPases 
and Rac, which both are known to be involved in actin cytoskeleton rearrangement 





1.6 BCR-mediated antigen internalization and processing for presentation 
B cells uptake, process and present antigen to acquire T cell help, which provides an 
essential signaling B cell activation and differentiation into memory B cells. While B 
cells can non-specifically internalize antigen via pinocytosis, BCRs render B cells the 
ability to capture specific antigen with high efficiency (78, 79). B cells are known to 
be able to internalize soluble antigens, membrane bound antigen, and immobilized 
antigens on non-internalizable surfaces. The efficiency of antigen internalization 
depends on BCR affinity for the antigen and the concentration or density of BCR 
binding epitope, as higher affinity and density induces greater levels of antigen 
internalization and therefore better presentation to T cells (64, 79-81). Soluble 
antigens are readily internalized with BCRs. A recent study has shown that B cells 
can extract antigen immobilized to a surface, and this process involves lysosomal 
secretion of hydrolases, which remove the antigen from non-internalizable surfaces 
(82, 83). It has also been shown that B cells can internalize antigen form 
immunological synapses formed with antigen presenting cells, where BCRs 
internalize antigen along with the target cell’s membrane (81, 84). Previous studies 
using in vitro approaches indicate that internalization of antigen by BCRs is clathrin 
and dynamin-dependent. 
 
The binding of antigen to BCRs at the surface induces the recruitment and 
accumulation of clathrin, leading to their confinement into clathrin coated pits and 




is controlled by the cytoplasmic domains of Igα and Igβ, both of which contain 
internalization motifs in their cytoplasmic domains (87, 88). Internalization signal 
domains are tyrosine-based motifs that are predicted to bind to endocytic adaptor 
proteins, specifically adaptor protein-2 (AP-2) (88-90). Upon binding to cytoplasmic 
signal domains of receptors, AP2 recruits clathrin to the plasma membrane. Along 
with curvature inducing proteins and other endocytic proteins, the clathrin-coated 
plasma membrane bends inward. The invagination of the plasma membrane forms a 
clathrin-coated pit at the membrane surface. Vesicle scission from the plasma 
membrane is then mediated through the GTPase, dynamin (91). For the 
internalization of membrane-associated antigen, non-muscle myosin II is required 
(84). Dynamin polymerizes at  the neck of the invaginated vesicle and actomyosin 
provides the tension needed to pull the vesicle from the plasma membrane into the 
cytoplasm (92). Dynamin has been shown to be recruited to the B cell surface via 
Linker of activated B cells (LAB) and Actin-binding protein 1 (Abp1). B cells with 
dynamin mutants and Abp1 gene knockout have impaired BCR internalization (91, 
93). There is a clathrin-independent and actin dependent mechanism reported for 
BCR internalization in B cells with clathrin heavy chain knockdown. This suggests 
that clathrin is not the only pathway for BCRs to internalize antigen (86). 
 
 
The clathrin-dependent internalization of antigen/BCR complexes requires 
lipid rafts, BCR signaling, and actin rearrangement. Pharmacological reagents that 




inhibit antigen/BCR internalization (85, 86, 94). This is likely because lipid rafts are 
required for forming BCR-signaling micodomains and it is within these 
microdomains that signaling and endocytic molecules are recruited and activated, 
including Vav, Bam32, clathrin, and dynamin (85, 91, 93, 95). Many of the signaling 
molecules known for internalization are involved in actin rearrangement, including 
Vav, Rac, Btk, Bam32, and Abp1. Actin rearrangement is necessary for antigen/BCR 
endocytosis, as disruption of actin dynamics by treatment with cytochalasin or 
latrunculin inhibits antigen/BCR internalization (86, 96). B cells deficient in Vav, a 
GTPase for Rac, or RNA interference of Vav inhibits Rac activation, which 
significantly reduces antigen/BCR internalization after BCR stimulation (91, 97). The 
recruitment and activation of Vav for internalization depends on the raft associated 
transmembrane protein, Linker of activated B cells (LAB), and Bruton’s tyrosine 
kinase (Btk) (91, 97, 98). Through Vav, Btk activates WASP, consequently inducing 
actin remodeling (72). Two other signaling molecules involved in actin-mediated 
antigen/BCR internalization include Abp1 and B lymphocyte adaptor molecule of 32 
kilodaltons (Bam32). Abp1is phosphorylated and recruited to the cell surface upon 
BCR engagement to antigen. Abp1 can interact with both F-actin and dynamin, 
potentially recruiting F-actin to dynamin-restricted clathrin-coated pits (93). Bam32 
regulates BCR internalization by inducing actin polymerization. It is phosphorylated 
by the Src tyrosine kinases upon BCR ligation and co-localizes with BCRs, lipid 
rafts, clathrin, and actin (95).        
After vesicle scission and entry into the cell, the antigen/BCR complexes are 




into multivesicular-late endosomes enriched in newly synthesized MHCII (99-101) 
(Fig. 1.6). The fast trafficking of antigen/BCR through endosomal compartments 
relies on BCR signaling, and cytoskeleton dynamics. Activation of Btk and 
recruitment of BLNK is necessary for trafficking and fusion of antigen/BCR 
containing vesicles with MHCII enriched late endosomes(72, 99). Both Igα and 
Igβ are also required for targeting antigen/BCR complexes to MHCII-rich 
compartments (87, 88, 102-104).  Trafficking between the endosomal compartments 
requires actin reorganization, which is mediated through Syk upon BCR stimulation. 
Prevention of Syk activation has been shown to inhibit the actin rearrangement 
required for movement and fusion of antigen/BCR containing vesicles with MHCII-
rich endosomes (96, 105). Along with actin, the actin-associated motor protein, 
myosin II, is necessary for converging antigen/BCR vesicles with MHCII-rich 
compartments. Myosin II has been shown to become activated during BCR 
engagement and thus similar to actin, relies on BCR-mediated signaling for 
trafficking antigen/BCR vesicles to MHCII enriched compartments (106). After 
reaching MHCII enriched late endosomes, antigen is fragmented by proteases and 
loaded onto MHCII molecules.  Peptide-loaded MHC II complexes are then exported 












Fig. 1.6: Antigen internalization, processing, and presentation. (1) BCR 
engagement induces signaling  in lipid rafts that leads to activation of molecules 
involved in actin reorganization. (2)Rearrangement of actin mediates internalization 
of the antigen/BCR complexes into clathrin coated vesicles that traffic and fuse with 
endosomes. (3) MHCII molecules are processed, sorted, and transported through the 
ER and Golgi and then (4) released in vesicles that move along microtubules to fuse 
with late endosomes. (5) Fusion of antigen/BCR containing endosomes with MHCII 
enriched late endosomes allows for degradation of the antigen by proteolytic enzymes 
and loading onto MHCII molecules. Before loading of antigen, MHCII molecules 
have their invariant chains catalytically removed by cathepsin S. (6) The antigen 
loaded MHCII molecules are then transported to the B cell surface via microtubules, 




















 1.7 Relationship between properties of antigen and the B cell response 
The properties of antigen determine the ability of antigen to stimulate B cells, thereby 
becoming a target of exploration for vaccine design. Increasing antigen avidity is a 
potential way to enhance its immunogenicity. Avidity measures the overall binding 
strength between an antigen and its cognate BCR, which depends on both the affinity 
and valency of the antigen (58). Affinity is the binding strength of an antibody to its 
cognate epitope, while valency is the number of identical epitopes on an antigen. 
Multivalent antigens containing multiple identical epitopes can cross-link multiple 
BCRs, which potentially overcomes low affinity interactions of BCRs with antigen 
(48). Avidity is key in determining how B cells respond to antigen, as high avidity 
induces greater activation of B cells, endocytosis of antigen, and thus enhanced 
presentation to T cells, which will in turn generate more help from T cells for 
antibody production and development into memory B cells  (64, 79-81).  
Antigens with higher affinity induce superior BCR signaling, B cell 
proliferation, antigen internalization and presentation to T cells, and antibody 
production compared to those with lower affinities. Studies using a model antigen, 
hen egg lysozyme (HEL), have demonstrated that the soluble wild type form of HEL 
induces higher levels of protein tyrosine phosphorylation, antigen internalization and 
presentation to T cells in MD4 transgenic mouse B cells that express HEL specific 
BCRs, compared to mutated and lower affinity HEL at the same concentration (25, 
80). With membrane bound HEL, it was discovered that wild type HEL produces 
greater B cell spreading, antigen accumulation, and intracellular calcium responses 




using different antigens in both soluble and membrane bound forms provoke 
enhanced B cell activation when having higher affinities to the BCRs. Soluble M13 
phage peptide with high affinity for 3-83 mouse BCRs induce greater calcium 
mobilization, tyrosine phosphorylation, cell proliferation, and antibody production 
compared to M13 phage peptides with lower affinities (107). Constructed BCRs with 
varying affinities for 4-hyroxy-3-iodo-5-nitrophenyl (NIP), showed that B1-8 B cells 
with high affinity BCRs had a faster calcium response and more quickly clustered 
BCRs that grew more rapidly than low affinity BCRs at the same concentration of 
NIP on artificial membranes (62).  
Corresponding to the effects of higher affinity, higher valency antigens also 
increase the activation of B cells and induce greater responses of proliferation, 
antibody production, antigen presentation and stimulation of T cells. BCR 
oligomerization by antigen cross-linking is required for activating  BCR signaling, as 
F(ab’)2 but not Fab fragment of anti-Ig activates B cells (108, 109). Due to this, 
techniques have been designed to increase the valency of antigens to enhance the 
avidity of antigens and efficiencies of antigen to induce BCRs to cluster together and 
to elicit B cell responses. The methods that have been employed to increase antigen 
valency include aggregation, cross-linking, attachment to immobilized substrates, and 
conjugation to a carrier molecule. Increasing valency is a much more practical way to 
enhance the avidity of antigens than increasing affinity. 
    
Aggregates of immunogens from pathogens and toxins have been and still are 




valency created from aggregation elicits enhanced antibody responses. Several 
methods are described for aggregation of antigens. One way is to heat the antigen 
until it denatures and clumps together. This strategy is an older method used with 
many pathogenic proteins, including cholera enterotoxin, which generated a better 
immunogen that induced high antibody production and increased resistance to lethal 
challenge in immunized mice (110). A much more common method used today is to 
produce protein immunogens with repetitive antigenic peptides using bioengineering 
methods. This type of technique is widely used for vaccine development and has been 
applied for designing vaccines against viruses such as dengue, hepatitis, and HIV 
(111-113), and bacterial toxins like botulinum neurotoxin and tetanus neurotoxin 
(114); all of which showed to elicit sufficient antibody responses that afforded 
protection against subsequent challenge in animal models.  
Chemical cross-linkers have been used to couple multiple antigens together. 
Multivalent antigens produced through cross-linking show to induce greater BCR 
signaling, antigen internalization and presentation compared to monovalent antigen in 
vitro. Glutaraldehyde was used to cross-link HEL to produce dimeric, trimeric, and 
tertrameric HEL. These multivalent HELs were shown to elicit increased 
phosphotyrosine levels, larger and sustained calcium responses, and greater 
presentation and ability to activate T cells compared to monomeric HEL (115). 
Streptavidin has been used to cross-link biotinylated antigens, which caused the BCR 
cap to persist longer at the cell surface and increased and prolonged tyrosine 




Another way to increase antigen valency is to link the antigens to immobilized 
substrates, such as beads or to carrier molecules, including polysaccharides, synthetic 
polymers, and peptides. Covalent attachment of antigens, such as trinitrophenyl, or 
anti-Ig antibody to polyacrylamide or agarose beads increases their ability to 
stimulate B cells and induce proliferation (108, 117, 118). Similarly, conjugating anti-
Ig antibodies to carrier molecules, such as polysaccharides, ficoll, or dextran, 
increases B cell proliferation, cell viability, antibody production, and expression of 
MHC II. Even low affinity anti-Ig antibodies were able to increase B cell activation 
conjugated to a carrier molecule (109, 119, 120). Other carrier molecules, like 
synthetic polymers or constructed peptides to which dinitrophenyl (DNP) or NIP 
were covalently linked to have shown to enhance BCR signaling, calcium flux, and 
antibody production, while their monovalent forms failed to elicit any B cell response 
at all (121, 122).  
Besides affinity and valency, the concentration of an antigen is also a factor in 
determining B cell responses, where increasing the concentration of an antigen 
increases its ability to activate B cells. Anti-Ig and its dextran conjugate can induce B 
cell proliferation only at higher concentrations (109). Similarly, increasing the density 
of the model antigen, HEL, on the surface of sheep red blood cells increases antibody 
production in MD4 mice. Higher densities of HEL attached to artificial membranes 
induces increased MD4 B cell spreading, HEL accumulation, HEL internalization, 
and presentation (25, 64). Even mutated HELs that bind to the BCR on MD4 B cells 
in relatively low affinities can activate B cells when attached on membrane at high 




antigen likely results from increased avidity of antigen due to valency increases (68, 
115).    
The effects of the properties of membrane bound antigen on B cell activation 
has not been as extensively studied as soluble. The majority of antigen presented to B 
cells in vivo are membrane bound (23), hence it is important to study the role of 
properties of membrane bound antigen on B cell activation. Little is known about the 
effects of valency of membrane bound antigen on B cell activation. Additionally, 
actin plays a crucial role in B cell activation, it is particularly important for B cell 
spreading on target membranes, which corresponds to antigen accumulation and BCR 
signaling (64). However, the role of antigen properties of membrane bound antigen 
on actin dynamics is unknown.      
 
1.8 Membrane damage and repair mechanisms 
1.8.1 Cell membrane damage 
Most types of cells are under threat of being damaged. For example, epithelial and 
muscle cells are continuously being exposed to strong mechanical forces. Muscle 
cells have their cell membranes torn during contraction and epithelial cells endure 
injuries such as scratches and punctures. These  wounds of the plasma membrane are 
observed in epidermal cells, cardiac muscle, and skeletal muscle through the use of 
small tracer molecules, such as dextran or peroxidase, that enter the cell through the 
damaged site (123). Another form of mechanical stress on the plasma membrane of 
cells is the tension and pulling at cell-cell contacts, such as during cellular migration 




chick heart fibroblasts always leave cellular pieces of themselves behind at the 
detachment site of the cell’s trailing edges (124). Antigen presenting cells (APCs) 
may have their membranes damaged at immunological synapses, where B cells and T 
cells extract antigens with the associated membrane of the APC. It has been 
demonstrated that during internalization of membrane bound antigen, B cells also 
internalize some of the target cell’s surface membrane (84). T cells also acquire 
membrane  and the cell surface molecules from APCs (125).  
Bacterial toxins, viruses, venom, and even immunological factors, such as 
perforin and complement, can damage cell membranes by forming pores and causing 
leakiness in the cells. There are approximately thirty bacterial species that produce 
pore forming toxins, including hemolysin produced by E.coli, pneumolysin produced 
by Streptococcus pneumoniae, streptolysin O (SLO) produced by Streptococcus 
pyogenes, and protective antigen (PA) by Bacillus anthracis. Many of the pore-
forming toxins are cholesterol dependent cytolysins, including the well studied SLO, 
which binds cholesterol and oligomerize to form pores in the plasma membrane. The 
diameter of SLO formed pores is about 30 nm in diameter (126, 127). Pore-forming 
toxins are imperative for microbial pathogenicity. Mutant bacterial strains that do not 
produce hemolysin or pneumolysin have reduced virulence. This is likely because the 
pores are required for microbial virulence factors to enter the host cells. For example, 
PA forms pores for toxin to enter the host cell (128, 129). The virulence of group A 
streptococcus (GAS) is enhanced by SLO, which aids in GAS escape from 
endosomal/lysosomal pathways following invasion of host cells (130). Viruses and 




hemolytic paramyxoviruses (measles and mumps), respiratory syncytial virus, and 
parainfluenza viruses, induce permeability changes to the plasma membrane of host 
cells during entry into the cell, by fusion of an inherently leaky viral envelope with 
the host’s plasma membrane (131). Bee venom, melittin, is also known to damage the 
plasma membrane of host cells and cause leakiness in cells (131).  
Immunological factors, such as complement and perforin, form pores within 
membranes to damage and/or lyse target cells. Although these factors are usually 
directed towards killing pathogens, defects may arise, leading to damages to 
bystander cells. Complement factors can directly bind to bacterial surfaces or 
antibody-oposonized pathogen, consequently assembling pores (membrane attack 
complex created by C5b-C9) that lyse and kill pathogen. Unregulated complement 
binding leads to complications in the host itself. For example, age-related macular 
degeneration is caused by a defect in the complement factor H. The complement 
factor H functions to prevent complement deposition on host cells. When factor H is 
defective, C5b-C9 is seen deposited in vessels and membranes of eyes of patients 
(132). Perforin, released by cytotoxic T cells, forms pores in target cells to allow 
access of granzymes and induction of apoptosis. Using this mechanism, cytolytic T 
cells kill virus infected cells and tumor cells (133, 134). Perforin binds 
phosphorylcholine moieties and oligomerize to form 16 nm pores within the plasma 





1.8.2 Cell membrane repair 
After membrane damage, cells repair quickly to survive, resealing the injured site to 
prevent lethal toxicity by massive extracellular calcium entry or loss of cytoplasmic 
constituents. Cells repair their injured membrane within seconds to a minute (123, 
136). For decades it has been known that extracellular calcium is required for 
membrane repair (137-139). The influx of calcium through the membrane wound 
triggers accumulation and exocytosis of intracellular vesicles to the site of injury 
(139-141). Using TIRFM, it was found that calcium-triggered exocytosis, primarily 
induces lysosomal fusion with the plasma membrane (142). Other studies support 
this, as lysosomal luminal domain marker, LAMP1, is seen on the cell surface of 
injured cells and lysosomal enzymes, β-Hexosaminidase (βHex) and acid 
sphingomyelinase (ASM), are detected in the extracellular media following damage 
(143, 144). Vesicle transport to the plasma membrane requires microtubules, as 
antibodies against kinesin inhibit fibroblast repair. In sea urchin eggs, vesicle 
transport by myosin is required and inhibitors of myosin prevent vesicle transport to 
the plasma membrane and decreased membrane repair (140, 145).  
In order for the intracellular vesicles to fuse with the plasma membrane, the 
cortical actin cytoskeleton requires remodeling. In fact, fibroblasts, neurons, and 
epithelial cells have enhanced resealing with actin destabilizing treatment, conversely 
actin stabilizing treatment inhibits repair (146). Upon reaching the plasma membrane, 
intracellular vesicles fuse with the plasma membrane via calcium-dependent vesicle 
fusion proteins. Synaptotagmins (Syts) are transmembrane proteins with two C2 




and soluble N-ethyl-maleimide-sensitive fusion protein attachment protein receptor 
(SNARE) complexes. SNARE proteins interact with each other to mediate 
intracellular membrane fusion events by providing the driving force to fuse lipid 
bilayers. In normal rat kidney epithelial cells (NRK), Syt VII regulates calcium 
triggered exocytosis of lysosomes. During calcium influx, Syt VII located on 
lysosomes interacts with the vesicle SNARE (v-SNARE), Vesicle-associated 
membrane protein 7 (VAMP-7). VAMP-7 then interacts with the target SNAREs (t-
SNAREs), SNAP-23 and syntaxin-4, on the plasma membrane to promote lysosomal 
fusion with the plasma membrane (144, 147-150).  
Other proteins are also implicated in fusing vesicles with the plasma 
membrane for repair. Dysferlin, a member of the ferlin family of proteins, have a 
similar protein structure to Syts and may play a role in vesicle fusion. Dysferlin is 
known to localize to wound sites during membrane repair and it has been 
demonstrated that dysferlin is required for muscle membrane repair, as dysferlin 
deficient mice do not repair their muscle membranes and show symptoms of muscular 
dystrophy (151, 152). Annexins have also been suggested to be involved in 
membrane fusion events for membrane repair. Annexins are known to mediate 
membrane fusion and annexin A1 has been shown to move to injured sites in a 
calcium dependent manner and bind to the plasma membrane in HeLa cells damaged 
by scrapping or laser injury. Further studies have demonstrated inhibition of 
membrane repair with the use of an annexin A1 function-blocking antibody and an 





1.8.3 Membrane repair by exocytosis or endocytosis 
Observation of vesicle exocytosis at wounded sites set the basis for the “patch 
hypothesis”, which explains the repair of massive membrane wounds, such as the 
severing of neurons, whereby entry of calcium causes rapid and enormous vesicle-
vesicle fusion events beneath the injury, forming a patch of vesicles that then fuses 
with the plasma membrane in a calcium dependent manner. In the case of massive 
wounding, it is believed that not just lysosomes are exocytosed to the plasma 
membrane, but all the available vesicles in the vicinity are used for the patch, 
including early and late endosomes (146). The patch hypothesis explains repair for 
very large injuries, however, cells damaged by small wounding, such as by pore 
forming complexes, repair quite differently.  
Cells injured by small wounding exocytose lysosomes and then complete the 
repair of their membrane by removing the lesions. It has been suggested that pore 
forming complexes are removed from the plasma membrane by enodocytic and/or 
exocytic processes (152). Exocytosis of membrane lesions involves blebbing and 
shedding of vesicles containing the lesions, whereas endocytosis of the lesions leads 
to eventual lysosomal degradation of the pore forming complexes. Blebbing is 
thought to trap the damaged membrane, where it is then sealed off from the cell body 
to prevent further influx of calcium, which may lead to cell death (152, 154). This has 
been demonstrated in perforin treated HeLa and U937 (monocyte lymphoma cell line) 
cells, where small molecular dyes, such as trypan blue, were confined within blebs, 
indicating that the perforin induced pores were isolated from the rest of the cell by the 




produce blebs and shed vesicles containing SLO pores. HEK 293 cells treated with 
SLO, translocates annexin A1 to the injured sites of calcium entry to form plugs at the 
neck of blebs and induce the shedding of vesicles containing SLO pores (152, 154, 
155). Along with annexin A1, endosomal sorting complex required for transport 
(ESCRT) is suggested to be involved in creating blebs and regulating vesicle 
shedding during various types of wounding, including permeabilization by saponin, 
digitonin, SLO, and laser wounding. ESCRT is known to play a role in various 
membrane fission events. In membrane repair, ESCRT-III is recruited to wounded 
sites and accumulates at blebs and vesicle shedding sites, suggesting that repair 
depends on ESCRT-mediated shedding of damaged membrane portions (156). 
Although there is evidence of blebbing and vesicle shedding, there is also evidence 
that blebs are retracted back into the cell rather than being shed. Studies have 
revealed that plasma membrane blebs induced by SLO may completely retract back 
into the cell body during repair and even micrometer-sized blebs induced by laser 
wounding have been seen to retract (138). 
Similar to shedding of vesicles, endocytosis promotes repair of membranes by 
removing the lesion from the plasma membrane. The endocytosis of membrane 
lesions has been intensely studied in epithelial and muscle cells. Using endocytosis 
markers, such as dextran and BSA, and visualizing the number of vesicles in TEM 
images, it was discovered that fibroblasts and myotubes treated with SLO or 
scratching have an increase in endocytosis compared to cells without wounding; and 
that in the case of SLO wounding, the SLO toxin proteins are internalized into 




complement has also been demonstrated to involve internalization of the injured site, 
where C5b-9 complexes are seen to be internalized by clathrin-coated pits and 
transported to multivescular bodies (160).  
The increase in internalization from membrane wounding is necessary for 
membrane repair and is mediated by acid sphingomyelinase (ASM), which is released 
from lysosomes during fusion with the plasma membrane and is detected in the 
surrounding media of cells treated with SLO (Fig.1.8). Treatment with the ASM 
inhibitor, desipramine (DPA), or using siRNA to silence ASM inhibits endocytosis 
and membrane repair in HeLa cells. Also Niemann-Pick type A cells, which are 
deficient in ASM, are defective in endocytosis and membrane repair, however, are 
rescued with extracellular addition of recombinant human ASM (143). The role of 
ASM in membrane internalization is likely due to its action on the outer leaflet of the 
plasma membrane to generate ceramide from sphingomyelin. Ceramide is smaller 
than other plasma membrane lipids and therefore microdomains of ceramide are 
pushed inward, forming invaginations; also ceramide is known to interact with lipid 
rafts, which may induce internalization (138, 143, 158). The endocytic molecules 
required for wound repair-mediated internalization includes cholesterol and caveolae, 
indicating that the internalization for membrane repair is lipid raft-dependent (161). 
Cholesterol depletion by MβCD treatment or RNAi-mediated silencing of Cav1 
expression inhibits endocytosis and wound repair (157, 158). In fact, it has been 
shown in SLO treated epithelial and muscle cells that SLO is internalized into 
caveolae vesicles and that injury by scratching increases the number of caveolae 






Fig.1.8. Membrane repair of SLO pores via endocytosis. SLO pores (red) allow 
entry of calcium into the cell. This induces exocytosis of lysosomes (green) and 
fusion of the lysosome with the plasma membrane. Exocytosis of lysosomes releases 
acid sphingomyelinase (ASM), which acts on sphingomyelin to generate ceramide. 
Ceramide microdomains are invaginated and along with caveolin, mediate 
endocytosis of the SLO pores. 
  




The last step for endocytosis is scission from the plasma membrane, which 
typically involves dynamin and actin, however, for epithelial cells damaged with  
SLO, dynamin and actin are not required for endocytosis and membrane repair. This 
was demonstrated using a dynamin mutant expressed in NRK cells, which had no 
effect on internalization and membrane repair when permeabilized by SLO. As for 
actin, disruption of the cytoskeleton by cytochalasin D actually enhances endocytosis 
and membrane repair in cells treated with SLO or injured by scratching, indicating 
that actin polymerization is not needed for endocytosis and repair (157, 158). 
Although damage by SLO is dynamin independent, other studies have revealed that 
damage by perforin induces a clathrin and dynamin dependent internalization and 
knockdowns of clathrin heavy chains and dynamin 2 inhibits endocytosis of perforin 
and prevents membrane repair (139, 162).  
Overall, for efficient membrane repair, there must be a calcium-triggered 
exocytosis of intracellular vesicles and removal of the membrane lesion. It has been 
suggested that the mechanism for membrane lesion removal depends on the type of 
cell and wounding, where one type of cell may repair differently from another type 
and this may contrast depending on the size and variety of wounding. Therefore, it 
may be more efficient for some cells to bud and exocytose membrane lesions, while 
for other cells, endocytosis works better for membrane repair (156). Endocytosis for 
repair requires caveolin, however, there are cell types that do not express caveolin, 
such as lymphocytes. If and how lymphocytes repair is unknown; their repairing may 






1.9 Role of lipid rafts in B cell activation 
Lipid rafts are dynamic structures of the outer leaflet of the plasma membrane and 
consist of cholesterol and sphingolipids. These structures are less fluid than the 
surrounding lipids and therefore serve as platforms for organizing and confining 
protein receptors for creating signaling domains (161). BCR signaling and 
internalization is known to require lipid rafts. Stimulated B cells show co-localization 
of cholesterol with BCR clusters and evaluation of isolated lipid rafts from activated 
B cells has shown that BCRs are immediately translocated to lipid rafts upon BCR 
stimulation, where interaction with lipid raft resident, Lyn, leads to their activation 
(163, 164). Fluorescence resonance energy transfer (FRET) studies have also 
demonstrated that engaged BCRs move into lipid rafts to associate with Lyn and 
propagate signaling. Additionally, FRET has shown that BCR association with lipid 
rafts is prolonged by cross-linking with the co-receptor CD19/CD21; indicating 
interaction between BCRs with co-receptors stabilizes the signaling domain (49). 
Following BCR entry into lipid rafts and phosphorylation, other signaling molecules 
are recruited to the rafts and activated, including Syk, Btk, Vav, and PLCγ2 (165). 
This signaling then leads to BCR endocytosis, where it has been demonstrated that 
lipid rafts are important for retaining the kinases and signaling molecules needed to 
recruit and activate endocytic molecules (85, 93, 164). 
The importance of lipid rafts for BCR signaling and internalization is 
observed with Epstein-Barr virus (EBV) infections. EBV inhibits BCR signaling and 




(LMP2A). LMP2A has a binding site for Lyn, which enables it to reside within lipid 
rafts and exclude BCRs. Latently infected B cells have LMP2A present in their lipid 
rafts, which prevents BCRs from entering the lipid rafts to signal and internalize, 
however, this allows for the cell to stay alive so that the virus may persist (165, 166). 
Lipid rafts may be disrupted by pore forming agents, antibiotics, and 
cholesterol depleting reagents. All of these reagents typically disrupt lipid rafts by 
interacting with cholesterol. Toxins like SLO bind cholesterol and create pores in cell 
membranes; antibiotics such as filipin and nystatin bind to and sequester cholesterol; 
and methyl-β-cyclodextrin (MβDC) is used to remove cholesterol from membranes 
(161). The role of filipin, nystatin, and MβDC on B cell activation have been 
examined, however, the role of SLO damage on BCR activation is not known. 
Disruption of lipid rafts by filipin inhibits calcium flux and activation of the signaling 
molecule, PLCγ2, however, treatment with MβDC enhances calcium flux from 
intracellular stores (167-169). MβDC and filipin both inhibit BCR movement into 
lipid rafts, yet these reagents induce tyrosine phosphorylation without BCR 
stimulation and release Lyn from lipid rafts (168). Additionally, nystatin inhibits 
BCR internalization (86). Taken together these studies demonstrate that lipid rafts are 
vital for regulating proper BCR signaling and internalization. Without lipid rafts to 
serve as platforms for BCR signaling, there is uncontrolled signaling, possibly 
because Lyn and other raft resident molecules are no longer retained in lipid rafts, 





Disruptions of lipid rafts may also occur through plasma membrane damage 
and wound repair. B cells may have their membranes damaged by bacterial toxins or 
mechanically injured during cell-cell interactions. It has been shown that activated B 
cells may transfer portions of their plasma membrane along with BCRs to bystander 
B cells through close cell-cell contact (170). Also B cells serve as APCs and T cells 
and B cells are able to remove membrane from APCs (84, 125). Epithelial and muscle 
cells repair damaged membranes by lipid raft endocytosis induced by ASM release 
from exocytosed lysosomes. For B cells, lipid raft internalization would reduce the 
availability of raft platforms for signaling, which in return could decrease signaling 
required for BCR internalization. Additionally, ASM release may alter lipid raft 
composition by decreasing sphingomyelin and increasing ceramide in the plasma 
membrane, which may also affect BCR signaling. 
 
1.10 Significance and aims 
B cells face membrane damage by toxins and mechanical stresses endured during 
migration and cell-cell contacts with other cells. The first part of this dissertation 
looks at the membrane repair mechanism of B cells and how this repair mechanism 
may affect the B cell’s response to antigenic stimulation. It is of interest to discover 
the membrane repair mechanism of B cells. In epithelial and muscle cells, caveolin is 
necessary for the endocytosis of damaged membrane to promote repair. As B cells do 
not express caveolae, their mechanism of repair may reveal an alternate route of 




activation may reveal how toxins or mechanical stress affect B cell signaling and 
what this means for the immunological functions of the repaired B cell.  
 
B cells are imperative for efficient immune responses to pathogens. They 
produce antibodies required for elimination of microbes and toxins. Vaccination 
relies on the appropriate stimulation to induce antibody production and development 
of memory B cells. In order to do this, the response of B cells to various forms and 
properties of antigen must be studied. Antigens in the form of membrane bound are 
more potent then soluble, however, the role of the properties of membrane bound 
antigen on B cell activation are not well understood. The second part of this 
dissertation addresses the effects of antigenic properties on a B cell’s response to 
membrane bound antigen. A novel membrane bound antigen system was employed to 
accurately determine the role of antigen density and valency on the early events of B 
cell activation, including actin dynamics, B cell spreading, BCR aggregation, and 
BCR signaling.   
 
1.10.1. Aim 1. The mechanism of B cell membrane repair and the role of 
membrane repair on B cell activation 
This aim was designed to determine the mechanism of repair of caveolin deficient 
primary cells and to also examine the effects of membrane repair on B cell activation. 
To do this, WT Bl6 mouse B cells were damaged with SLO and examined for 




cell activation, SLO treated B cells stimulated with antigen were examined for 
changes in tyrosine phosphorylation (pY), BCR capping, and BCR internalization.  
 
1.10.2 Aim 2. The role of different properties of membrane bound antigen on 
early B cell activation 
This aim was designed to examine how density and valency of membrane bound 
antigen influences B cell activation. A novel antigen tethered membrane system was 
developed to present optimally oriented antigen to BCRs. The role of antigen density 
on actin dynamics, B cell spreading, and BCR aggregation was examined using live 
imaging of Lifeact primary mouse B cells. For studying effects of valency on B cell 
activation, B cell spreading, BCR aggregation, and BCR signaling of WT primary B 
cells were compared between stimulation with either monovalent or bivalent 













Chapter 2: Lipid raft-dependent plasma membrane repair 




Cells rapidly repair plasma membrane (PM) damage by a process requiring Ca2+-
dependent lysosome exocytosis. Acid sphingomyelinase (ASM) released from 
lysosomes induces endocytosis of injured membrane through caveolae, membrane 
invaginations from lipid rafts. How lymphocytes, lacking any known form of 
caveolin, repair membrane injury is unknown. Here we show that B-lymphocytes 
repair PM wounds in a Ca2+-dependent manner. Wounding induces surface exposure 
of the lysosomal protein LIMP2, ASM release, and endocytosis of the lipid-raft 
marker cholera toxin and dextran. Resealing is reduced by ASM inhibitors and ASM 
deficiency, and enhanced by extracellular exposure to ASM. B-cell activation via B-
cell receptors (BCRs), a process involving lipid rafts, interferes with PM repair. 
Conversely, wounding inhibits BCR signaling and internalization by disrupting BCR 
co-clustering with lipid rafts, while inducing endocytosis and formation of tubular-
shaped vesicles. Plasma membrane repair and B-cell activation may interfere with 
one another due to competition for lipid rafts, revealing how frequent membrane 







Plasma membrane wounding can occur during the lifetime of most cells, either by 
external mechanical forces generated by neighboring or pathogenic cells (171, 172), 
pore-forming proteins secreted by pathogens (128), or even internal mechanical 
forces generated by cell contraction and migration (124, 173, 174). Eukaryotic cells 
can rapidly repair wounds in the plasma membrane, thus avoiding lethal events 
triggered by massive Ca2+ influx and cytosol depletion (136). The importance of 
plasma membrane repair has been demonstrated particularly in muscle fibers, which 
are frequently injured during contraction. Failure in resealing of the muscle 
sarcolemma has been identified as a cause of muscular dystrophy (151).  
Early studies discovered that the rapid membrane repair mechanism is 
triggered by Ca2+ influx through wounds in the plasma membrane (138, 140). The 
Ca2+ flux induces lysosome exocytosis, which exposes lumenal lysosomal membrane 
proteins on the cell surface and releases lysosomal contents (142-144). Exposure of 
the lumenal domain of lysosomal membrane proteins, such as the lysosomal-
associated membrane protein 1 (LAMP-1) and the lysosomal synaptotagmin isoform 
Syt VII are detected a few seconds after wounding, reflecting the Ca2+-dependent 
fusion of lysosomes with the plasma membrane (144). Exocytosed lysosomes were 
initially suggested to provide the membrane needed for wound sealing, working like a 
patch to repair open wounds. More recently, it became evident that lysosomal 
exocytosis is followed by a rapid form of endocytosis that can remove lesions from 




Recent studies revealed that plasma membrane wounding by the pore-forming 
streptolysin-O (SLO) or by mechanical forces triggers endocytosis of caveolae (158), 
plasma membrane invaginations that are preferentially localized in lipid rafts of the 
plasma membrane (175). Evidence supporting this finding includes the co-
localization of caveolin and SLO in <80 nm intracellular vesicles, accumulation of 
budding vesicles with morphological characteristics of caveolae (<80 nm diameter 
budding vesicles that are flask shaped and lack a dense coat) (176) at wound sites in 
cell lines and primary muscle fibers (158), and inhibitory effects of caveolin 
knockdown on plasma membrane repair (158, 177). The involvement of caveolae in 
the endocytosis-mediated plasma membrane repair process is also consistent with the 
severe muscle pathology that is observed in mice deficient in caveolin and other 
caveolae-associated proteins such as cavin (178, 179). 
 Caveolin-mediated endocytosis of injured plasma membrane was shown to be 
induced by acid sphingomyelinase (ASM) (143). Via Ca2+-dependent lysosome 
exocytosis, ASM is released to the outer leaflet of the plasma membrane, where it 
generates ceramide from sphingomyelin (180, 181). Ceramide was proposed to 
induce caveolae-mediated endocytosis by facilitating the recruitment of caveolin to 
lipid rafts and by creating membrane curvature (138). The importance of ASM in 
plasma membrane repair has been demonstrated by the finding that extracellular 
exposure to ASM restores membrane resealing even in the absence of extracellular 
Ca2+ (182). Moreover, inhibition or depletion of ASM reduces wounding-induced 
endocytosis and plasma membrane resealing (143). Thus, increasing evidence 




caveolin-mediated endocytosis as an important mechanism for plasma membrane 
repair. However, it is not known if this form of plasma membrane repair is universal, 
or if different cell types that express distinct regulatory proteins have distinct 
mechanisms to reseal after injury.  
Lymphocytes are unique, non-adherent cells that attach to substrates and 
migrate in response to stimuli (183, 184). After maturation in the bone marrow or 
thymus, lymphocytes circulate through the body in order to survey for the presence of 
pathogenic substances. In response to pathogenic signals, lymphocytes extravasate, 
migrating through endothelial cells to reach infected sites. In addition, lymphocytes 
migrate through dense and well-organized lymphoid tissues, the spleen and lymph 
nodes, where they recognize antigen presented by antigen-presenting cells and mount 
responses (23, 185). B-cells extract antigen from antigen-presenting cells, internalize 
and process antigen in late endosomes, and present antigen for T cell recognition 
(185, 186). Through these processes, lymphocytes face ample possibilities of 
wounding their plasma membrane, such as encountering pore-forming bacterial toxins 
or complement proteins in infection sites, and particularly, mechanical damage from 
T cells during antigen presentation, where it has been shown that T cells are able to 
remove membrane from antigen presenting B cells (187) . However, unlike epithelial 
cells, fibroblasts and myofibers which have been well studied regarding their plasma 
membrane repair ability, nothing is known about how lymphocytes cope with injury. 
Different from those well studied cells, lymphocytes do not contain detectable levels 
of known isoforms of caveolin (188), even though B-cells have been reported to 




apparent lack of caveolin, the organization of signalosomes and the endocytotic 
machinery in lymphocytes is known to be highly dependent on lipid rafts (49, 85, 93, 
164, 165), plasma membrane domains where caveolin normally resides (175). B-cell 
activation is induced by the B-cell antigen receptor (BCR). Upon antigen binding, 
surface BCRs oligomerize into microclusters in lipid rafts, where the cytoplasmic 
tails of the receptor are phosphorylated by raft-resident Src kinases in the inner leaflet 
of the plasma membrane. The phosphorylated cytoplasmic domains of the BCR 
recruit and activate downstream signaling molecules, propagating signaling cascades 
(42, 165). In addition, lipid rafts are also essential for BCR internalization, by which 
B-cells capture, uptake, and transport specific antigen for processing and presentation 
(86, 94). We have demonstrated that lipid rafts act to couple BCR signaling and 
endocytosis by recruiting endocytotic machinery proteins to the vicinity of 
signalosomes for activation (72, 85, 93). The unique properties of lymphocytes, the 
importance of lipid rafts in their functional properties, and the fact that injury is likely 
to occur as these cells migrate in vivo, raise the question of whether and how 
lymphocytes repair plasma membrane wounds.  
In this study, we show that primary B-lymphocytes can effectively repair 
membrane wounds in the absence of caveolin. The membrane repair process depends 
on Ca2+ influx, Ca2+-induced lysosome secretion, and lipid raft-mediated endocytosis. 
Our results suggest that the plasma membrane repair mechanism inhibits the signaling 
and antigen internalization functions of the BCR by interfering with access of the 








2.3 Materials and Methods 
 
Mice and B-cell isolation 
Splenic B-cells were isolated from wild type (C57BL/6) (Jackson Laboratories) and 
ASM KO mice (C57BL/6 background, kindly provided by Dr. Edward Schuchman at 
Mount Sinai School of Medicine and Dr. Silvia Muro at University of Maryland). 
Mononuclear cells were enriched by Ficoll density-gradient centrifugation (Sigma-
Aldrich). T cells were removed by anti-Thy1.2 mAb (BD Biosciences) and guinea pig 
complement (Rockland Immunochemicals), and monocytes and dendritic cells by 
panning. All procedures involving mice were approved by the Institutional Animal 
Care and Usage Committee of the University of Maryland.  
 
Plasma membrane repair assays 
Freshly isolated B-cells were incubated with SLO in either Ca2+-containing (+Ca2+) 
or Ca2+-free DMEM (-Ca2+) for 5 min at 4°C to allow binding. Cells were then 
warmed to 37°C for 5 min, immediately transferred to 4oC and stained with the 
membrane impermeant dye propidium iodide (PI). Cells were analyzed using a BD 
FACS Canto II flow cytometer and Flowjo software (Tree Star, Inc.). The percentage 
of cells repaired in the presence of Ca2+ (+Ca2+) was determined by [%PI positive (-




sphingomyelinase (SM) on plasma membrane repair, SM from Bacillus cereus 
(Sigma) (50 µM) was included in the medium during the 37°C incubation.  
 
To analyze the effect of BCR cross-linking on the efficacy of plasma membrane 
repair, surface BCR were labeled with fluorescently conjugated Fab fragments of goat 
anti-mouse IgM (10 µg/ml, -XL) or F(ab)2 fragment of goat anti-mouse IgM (10 
µg/ml, +XL) (Jackson Immunoresearch) at 4oC. After washing off unbound 
antibodies, the cells were then treated with SLO (200 ng/ml) and analyzed as 
described above. 
 
Analyses of lysosomal exocytosis  
B-cells were incubated with SLO (200 ng/ml) for 5 min at 4°C and then 37°C for 5 
min. Cells were transferred to 4oC, stained with rabbit anti-LIMP2 antibody (Sigma) 
and Cy3-Fab-goat anti-mouse IgM+G for the BCR (Jackson Immunoresearch) at 4oC 
without permeabilization, and fixed with 4% paraformaldehyde. Cells were then 
analyzed by flow cytometry (BD FACS Canto II) and confocal fluorescence 
microscopy (Zeiss LSM 710; Carl Zeiss Microscopy, Thornwood, NY). 
 
Acid sphingomyelinase secretion and inhibition 
The secretion of ASM was analyzed by measuring the enzymatic activity of ASM in 
supernatants. Cells were treated with SLO (200 ng/ml) for 5 min at 4°C, warmed to 
37°C for 15 sec, and immediately cooled on ice. The supernatants were collected by 




determined using an Amplex Red sphingomyelinase assay kit (Molecular Probes), 
based on manufacturer-provided protocols. Supernatants were also concentrated using 
centrifugal filtration (Millipore) and analyzed by Western blotting, using rabbit anti-
ASM antibody (Abcam). To inhibit ASM, B-cells were pre-incubated with 30 µM of 
Desipramine (DPA) (Sigma) for 30 min at 37°C. Cells were then treated with SLO as 
described above.  
 
Dextran endocytosis 
B-cells were incubated with SLO (200 ng/ml) for 5 min at 4°C, in the presence of 2.5 
mg/ml of 10 kDa lysine fixable Texas Red-dextan (Invitrogen). The cells were 
warmed to 37°C for 5 min, washed to remove dextran that was not associated with 
cells, and fixed. The cells were then stained with Alexa Fluor 488 goat anti-mouse 
IgG (Invitrogen) to mark surface BCRs and imaged by confocal fluorescence 
microscopy (Zeiss LSM 710; Carl Zeiss Microscopy, Thornwood, NY). For SM 
treatment, 50 µM of sphingomyelinase (Sigma) was added prior to the 37°C 
incubation. 
 
BCR capping and activation 
B-cells were labeled and/or activated with Cy3-Fab-goat-anti-mouse IgG (Jackson 
Immunoresearch) or AF546-F(ab)2-goat-anti-mouse IgG (Invitrogen) at 4
oC for 30 
min, followed by AF488-CTB (Invitrogen) for 10 min. Cells were washed to remove 
unbound antibody and CTB, and then incubated with SLO (200 ng/ml) for 5 min at 




imaged using a confocal microscope (Zeiss LSM 710; Carl Zeiss Microscopy, 
Thornwood, NY). For each condition, more than 80 cells were analyzed for each of 
four independent experiments. 
 
For phosphotyrosine staining, B-cells treated as described above were permeabilized 
with 0.05% saponin and incubated with anti-phosphotyrosine mAb 4G10 (Millipore), 
followed by AF488 goat anti-mouse IgG2b secondary antibody (Invitrogen). Cells 
were analyzed by confocal microscopy (Zeiss LSM 710; Carl Zeiss Microscopy, 
Thornwood, NY) and flow cytometry (BD FACS Canto II).  
 
Flow cytometry analysis of BCR endocytosis 
B-cells were incubated at 4°C with biotinylated F(ab’)2 fragments of goat-anti-mouse 
IgM+IgG (Jackson Immunoresearch) for 30 min. The cells were then incubated with 
SLO (200 ng/ml) at 4°C for 5 min, warmed to 37°C and fixed at indicated times. The 
samples were labeled with PE-streptavidin (BD Bioscience) and analyzed using flow 
cytometry (BD FACS Canto II).  
 
Live cell imaging of BCR/CTB internalization 
The surface BCRs were labeled and activated with AF546-F(ab’)2-goat anti-mouse 
IgG and lipid rafts by AF488-CTB (Invitrogen). After 5 min incubation with SLO 
(200 ng/ml) at 4°C, time lapse images were acquired at 37oC using a Leica SP5 
confocal microscope. Kymographs were constructed using Andor IQ to track the 




BCRs with CTB at 10 min was determined using Leica LAS AF Lite imaging 
software. For each condition, more than eight cells were analyzed for each of three 
independent experiments. 
 
Immunoelectron microscopy analysis of BCR and CTB distribution  
The surface BCRs were labeled with 18 nm gold-conjugated goat anti-mouse 
IgG+IgM (Jackson Immunoresearch) and lipid rafts by biotinylated CTB (Invitrogen) 
followed by 10 nm gold-conjugated streptavidin (Sigma) at 4°C. Cells were then 
incubated with SLO (200 ng/ml) for 5 min at 4°C, warmed to 37°C for 1 and 5 min, 
and fixed with 2% glutaraldehyde. The cells were post-fixed by 2% osmium 
tetroxide, embedded in Spurr’s replacement embedding medium (Electron 
Microscopy Sciences), and imaged by transmission EM (Zeiss EM 10CA). For each 




Statistical analysis was performed by the two-tailed Student's t test using Prism 







Primary mouse B-cells repair plasma membrane wounds in a Ca2+-dependent 
manner 
In order to determine whether B-cells are capable of repairing wounds in the plasma 
membrane, primary B-cells, freshly isolated from mouse spleens, were incubated with 
increasing concentrations of SLO (0-400 ng/ml) with or without Ca2+ in the culture 
medium. SLO is a bacterial toxin that binds to cholesterol in membranes, 
oligomerizes and forms pores, thus permeabilizing the plasma membrane. SLO may 
bind to cholesterol in membranes in the presence or absence of Ca2+ (157). Cell 
nuclei were stained with the membrane impermeant dye propidium iodide (PI) 5 min 
post SLO exposure. B-cells that were injured by SLO and did not repair became PI 
positive (PI+). The percentage of PI+ cells was quantified by flow cytometry. In the 
absence of SLO, a small percentage of cells were PI+ in the presence or absence of 
extracellular Ca2+ (Fig. 2.1 A), as primary mouse B-cells can undergo spontaneous 
apoptosis gradually in the absence of stimuli (190, 191). In the absence of Ca2+, the 
percentage of PI+ B-cells increased with the concentration of SLO, and reached a 
plateau when the concentration reached 200 ng/ml (Fig. 2.1, A-B). In the presence of 
Ca2+, the percentages of SLO-treated PI+ cells were significantly decreased, compared 
to B-cells treated with SLO in the absence of Ca2+. In the presence of Ca2+ the 
percentage of PI+ cells was reduced from ~70% to ~30% when the SLO concentration 
was 200 ng/ml (Fig. 2.1, A-B), indicating that almost half of SLO damaged cells were 

























Fig. 2.1.  Mouse primary B cells repair SLO-induced membrane damage in a 
calcium-dependent manner. Primary mouse B cells were incubated with SLO (0 to 
400 ng/ml) at 4oC for 5 min and warmed up to 37°C for 5 min in medium with or 
without calcium. The percentage of PI+ cells were quantified as non-repaired cells 
using flow cytometry (A) and normalized to untreated cells (B). The percentage of 
cells repaired was calculated as described in the methods section:                           
[%PI positive (-Ca2+) - %PI positive (+Ca2+)] x 100/%PI positive (-Ca2+) (C). Shown 
are representative histograms (-Ca2+ solid line, -Ca2+ dashed line) (A) and the mean 
















Ca2+ the percentage of PI+ cells increased with the concentration of SLO, showing a 
reduced resealing capacity of B-cells as the SLO concentration rose (Fig. 2.1, B-C).  
These results indicate that primary mouse B-cells are capable of repairing plasma 
membrane wounds caused by SLO, and that plasma membrane repair in B-cells is a 
Ca2+-dependent process. 
Wounding-induced lysosomal exocytosis is involved in B-cell plasma membrane 
repair 
Cell wounding induces lysosomal exocytosis, and acid sphingomyelinase (ASM) 
released from lysosomes is required for plasma membrane repair in epithelial cells, 
fibroblasts and myofibers (143, 158). In contrast to these types of cells, resting 
primary lymphocytes are significantly smaller and thought to have fewer lysosomes 
and limited volumes of cytoplasm per cell (192, 193). This raises the question of 
whether wounding the plasma membrane of primary lymphocytes induces lysosome 
exocytosis, and whether lysosome exocytosis is important for plasma membrane 
repair in these cells. We analyzed lysosomal exocytosis in SLO-wounded primary B-
cells by surface detection of the lysosomal membrane protein LIMP2, and release of 
the lysosomal  enzyme ASM into the medium. Surface LIMP2 was detected using an 
antibody specific for the lumenal domain of the protein, by both immunofluorescence 
and flow cytometry without permeabilizing the cells. After 5 min of SLO treatment, 
LIMP2 was readily detected at the surface of SLO-treated B-cells identified by 
surface BCR labeling, but not at the surface of untreated B-cells (Fig. 2.2 A). Flow 
cytometry analysis quantitatively confirmed the immunofluorescence microscopy 







Fig. 2.2. Membrane repair in B cells partially depends on lysosomal secretion 
and ASM release.  (A) Fluorescence confocal images of LIMP2 staining on the 
membrane surfaces of B cells. Scale bar, 2.5 µm. B cells were exposed to SLO for 5 
min at 37˚C and stained for LIMP2 and BCRs at 4˚C without permeabilization. (B) 
The mean fluorescence intensities of LIMP2 staining on the membrane surfaces of B 
cells with or without SLO exposure measured by flow cytometry. Shown is the mean 
(±SD) of three independent experiments. (C) Activity of ASM released from B cells 
into the medium. B cells were exposed to SLO for 15 sec at 37˚C, protease inhibitors 
were added and the cells were immediately put on ice. The supernatant was collected 
and the ASM activity in the supernatants was detected using Amplex Red 
Sphingomyelinase assay kit, as relative fluorescence units (RFU). Shown is the mean 
(±SD) of three independent experiments. (D) Release of ASM into the medium was 
detected using western blotting. (E) Percentage of B cells repaired after exposure to 
SLO in the presence or absence of the ASM inhibitor, Desipramine (DPA). B cells 
were pre-incubated with 30 µM of DPA for 30 min at 37°C before 5 min exposure to 
SLO, followed PI staining and flow cytometry analysis. (F) Comparison of the repair 
efficiency of B cells from wild type (WT) or ASM KO mice. (G) Comparison of the 
repair efficiency of B cells in the presence or absence of calcium and 
sphingomyelinase (SM). B cells were pretreated with SM (50 µM) before SLO 
exposure, followed by PI staining and flow cytometry. Shown are the means (±SD) of 





and the amount of protein released into the supernatant of the B-cell cultures. The 
level of ASM activity in the supernatant of B-cells treated with SLO was significantly 
higher than that of untreated B-cells (Fig. 2.2 C). Consistently, there was a much 
higher level of ASM protein in the supernatant of B-cells injured by SLO than that of  
untreated B-cells, as shown by western blot (Fig. 2.2 D). These results indicate that 
injury of the B-cell plasma membrane induces lysosome exocytosis. 
To determine whether injury-induced release of active ASM is required for B-
cells to repair their plasma membrane, we inhibited ASM by a potent inhibitor, 
desipramine (DPA) (194) or used primary B-cells from ASM knockout mice (195). 
DPA treatment reduced the capability of B-cells to repair their plasma membrane by 
50%, the same percentage of inhibition previously observed in SLO-wounded NRK 
cells (143). On the other hand, B-cells from ASM knockout mice only showed a 
~10% reduction of plasma membrane repair. Since the later results could have been a 
consequence of compensatory mechanisms developed in ASM knockout mice, we 
investigated whether addition of purified SM extracellularly, mimicking ASM 
secretion, was able to restore B-cell plasma membrane repair capability, when the 
process is blocked by the lack of extracellular Ca2+. Consistent with the results from 
ASM inhibition, the incubation of SLO-treated B-cells with ASM in the absence of 
Ca2+ significantly increased the percentage of B-cells that fully resealed their plasma 
membrane (Fig. 2.2 G). These data suggest that plasma membrane repair in B-cells 




B-cell injury by SLO induces ASM-dependent fluid phase and lipid raft-
mediated endocytosis  
Endocytosis of caveolae was shown to be involved in the repair of plasma membrane 
wounds in fibroblasts and muscle fibers (158). To determine whether wounding the 
plasma membrane of B-cells, which do not express any known forms of the caveolar 
protein caveolin, also induces endocytosis, we utilized Texas Red-dextran to follow 
non-specific fluid phase pinocytosis by immunofluorescence microscopy, and cholera 
toxin subunit B (CTB) for monitoring lipid raft-dependent endocytosis by 
immunoelectron microscopy. CTB binds glycosphingolipid GM1 which is enriched in 
lipid rafts, the same membrane domain from where caveolae-mediated endocytosis 
normally occurs. Dextran endocytosis, detected by the appearance of punctate 
staining within the cell, was significantly increased after 5 min exposure of B-cells to 
SLO, when compared to untreated B-cells (Fig. 2.3, A-B). These results indicate that 
plasma membrane wounding triggers rapid endocytosis of dextran by B-cells. To 
determine whether the dextran endocytosis induced by SLO permeabilization is 
dependent on ASM released by lysosomal secretion, we examined the effect of 
extracellular treatment with ASM on dextran endocytosis. We found that ASM 
treatment alone induced dextran endocytosis to a level similar to SLO treatment (Fig. 
2.3 B). These results suggest that the rapid fluid phase endocytic process triggered by 
wounding in B-cells is ASM-dependent. 
We next quantified the endocytosis of CTB, a measure of lipid raft 
endocytosis, by determining the percentage of surface bound biotin-CTB (marked by 








Fig. 2.3. Membrane damage by SLO increases endocytosis. (A) Confocal 
fluorescence microscopy images of Texas Red-dextran endocytosed at 5 min. B cells 
were incubated with or without SLO at 4°C for 5 min, and dextran was added right 
before the 37°C incubation for 5 min. Cells were then washed, fixed, and staining 
with Alexa Fluor 488 goat anti-mouse IgG to mark the surface BCR. Scale bar, 2.5 
µm. (B) Quantification of the percentage of B cells with internalized dextran in the 
presence or absence of SM by visual inspection of confocal images. Shown is the 
mean (±SD) of three independent experiments. (C) TEM analysis of the percentage of 
gold labeled CTB inside B cells. B cells were incubated at 4oC for 15 min with biotin-
CTB followed by 30 min with gold-strepavidin (10 nm), and then treated with SLO 
for 1 and 5 min at 37oC. Shown is the mean (±SD) of more than 16 individual cells 














microscopy (TEM). We found that the number of CTB gold particles inside 
intracellular vesicles was increased after 1 and 5 min of SLO treatment, compared to 
B-cells that were not treated with SLO (Fig. 2.3 C). Using TEM analysis, we did not 
observe accumulation of a great number of caveolae-like vesicles (<80 nm diameter 
and flask shaped) within wounded B-cells (data not shown), as previously shown in  
fibroblasts and muscle cells (158), consistent with the absence of caveolae in B-cells. 
Together, these results indicate that plasma membrane wounding induces caveolae-
independent fluid phase and lipid raft-based endocytosis in B-cells, a process 
regulated by the lysosomal enzyme ASM. 
  
Lipid raft endocytosis is important for B-cell plasma membrane repair 
While B-cells do not express classical caveolin, BCR signaling and endocytosis 
induced by antigenic ligands require the reorganization of lipid rafts and the actin 
cytoskeleton (86, 96, 165). To determine whether lipid raft endocytosis is important 
for B-cell membrane wound repair, we perturbed lipid rafts by cross-linking (XL) 
BCRs using antibodies, which activates receptor signaling and endocytosis as well as 
actin remodeling (61, 164). We found that BCR cross-linking significantly reduced 
the percentage of B-cells that repaired SLO wounds (Fig. 2.4 A), and nearly 
abolished the SLO-induced rapid endocytosis of CTB (Fig. 2.4 B). To determine 
whether actin dynamics is involved in plasma membrane repair in B-cells, we 
disrupted or stabilized actin filaments by pretreating B-cells with latrunculin or 
jasplakinolide. Both treatments significantly reduced the percentage of B-cells that 







Fig. 2.4.  BCR activation and actin disruption interfere with the B cell’s repair 
process of SLO-mediated membrane damage. (A) Percentage of  cell repair after 5 
min of SLO exposure in the presence or absence of BCR activation by cross-linking 
antibody. B cells were incubated with either Fab or F(ab’)2-anti-mouse IgM for 20 
min at 4oC and treated with SLO for 5 min at 37˚C, followed by PI staining. Shown is 
the mean ±SD of three independent experiments. (B) Quantification of the percentage 
of surface labeled CTB internalized in the presence or absence of SLO and BCR 
cross-linking antibody. B cells were incubated with or without anti-mouse IgM, 
biotin-CTB, gold-strep, and SLO at 4oC and warmed to 37˚C for 1 min, then 
processed for TEM. The percentage of gold particles inside individual cells were 
determined using TEM images. Shown is the mean ±SD of two independent 
experiments. (C) Disruption of actin during SLO injury decreases membrane repair. B 
cells were incubated at 37˚C with either Latrunculin B (10 µM) or jasplakinolide (2 
µM) for 30 min before 5 min exposure to SLO. PI was added and the samples were 
run on a flow cytometer to identify the percentages of PI+ cells. Shown is the mean 




wounding-induced endocytosis mediates plasma membrane repair in B-cells, and that 
BCR activation inhibits repair, possibly by interfering with lipid raft endocytosis and 
remodeling actin. 
Repair of plasma membrane wounding by SLO inhibits the formation of BCR 
signalosomes in lipid rafts 
Lipid rafts are critical for B-cell activation by serving as a platform for both BCR 
signalosomes and endocytosis (44, 164). We investigated whether the plasma 
membrane repair process, which also depends on lipid rafts, has any impact on the 
BCR signaling and antigen uptake functions. As both these functions are initiated by 
BCR clustering in lipid rafts, we analyzed BCR clustering and BCR-lipid raft co-
clustering using immunofluorescence microscopy. Surface BCRs were labeled and 
activated with fluorochrome-conjugated F(ab’)2
 fragment of anti-mouse IgM+G 
antibody, and lipid rafts were visualized with fluorescently labeled CTB. To prevent 
any possible effect of CTB on BCR clustering, CTB staining was carried out post 
BCR activation and at 4oC. Similar to what we previously showed (116), BCR cross-
linking induced clustering of surface BCRs to one pole of the cell, forming a 
polarized cap (Fig. 2.5 A). SLO wounding significantly reduced the percentage of B-
cells with BCR caps, from ~55% to ~35% (Fig. 2.5 B). Even though ~35% of SLO-
treated B- cells did display polarized distribution of surface BCRs in response to BCR 
cross-linking, the BCR clusters formed were looser and more spread out than those 
observed in untreated B-cells (Fig. 2.5 A). In the absence of SLO, most of B-cells 








Fig. 2.5.  SLO injury reduces BCR activation and internalization. (A-C) 
Immunofluorescence microscopy analysis of BCR-CTB co-clustering in the presence 
or absence of SLO. B cells were incubated at 4oC with Alexa Fluor 546 conjugated 
Fab or F(ab’)2 anti-mouse IgM  plus Alexa Fluor 488-CTB, and then warmed to 37˚C 
for 5 min with or without SLO, followed by fixation. Shown are representative 
images (A, scale bar, 2.5 µm) and the average percentages (±SD) of B cells exhibiting 
polarized BCR clusters among all B cells (B) and BCR-CTB co-clusters among all B 
cells with polarized BCR clusters (C) by visual inspection of confocal images from 
four independent experiments (***P=0.0004***P=0.0009). (D and E) Tyrosine 
phosphorylation (pY) analysis of stimulated B cells treated with or without SLO. B 
cells were incubated at 4oC with SLO, Alexa Fluor 546 F(ab’)2-goat anti-mouse IgM, 
and warmed to 37˚C for 5 min, followed by fixation. Cells were then permeabilized, 
stained for phosphotyrosine, and analyzed using confocal microscopy (D) and flow 
cytometry (E). Shown are representative images, Scale bar, 5 µm, (D) and the average 
(±SD) of the mean fluorescence intensities of phosphotyrosine from three 
independent experiments (****P<0.0001). (F) Quantification of the effect of SLO 
treatment on BCR internalization. B cells were incubated at 4oC with biotinylated 
F(ab’)2-anti-mouse IgM, followed by 37˚C incubation with or without SLO for 
indicated times. Cells were then fixed, labeled with PE-strepavidin and analyzed 
using a flow cytometer to determine the percentage of surface labeled BCRs 
remaining on the cell surface. Shown is the average percentage (±SD) from three 




decreased the percentage to ~55% (Fig. 2.5 A, C). These results indicate that the 
repair process of plasma membrane wounds inhibits BCR clustering in lipid rafts.  
To determine whether the inhibition of BCR-CTB co-clustering affects BCR 
signaling triggered by receptor cross-linking, we examined tyrosine phosphorylation 
as a measurement of signaling levels. Immunofluorescence microscopic analysis 
showed bright staining of anti-phosphotyrosine antibody in BCR caps of untreated B-
cells, 5 min post cross-linking. However, most of the SLO-treated cells failed to form 
BCR caps and exhibited much weaker and uniformly distributed phosphotyrosine 
staining (Fig. 2.5 D). Confirming the results from immunofluorescence, quantitative 
analysis by flow cytometry showed much lower phosphotyrosine mean fluorescence 
intensity in SLO-treated B-cells when compared to untreated B-cells (Fig. 2.5 E).  
We next determined the effect of SLO-induced plasma membrane wounding 
on BCR endocytosis using flow cytometry. We measured the percentage of reduction 
in the amount of surface labeled BCR over the incubation time at 37oC to reflect BCR 
endocytosis. SLO treatment reduced both the kinetics and the overall levels of BCR 
internalization (Fig. 2.5 F). At 20 min, there was still ~50% of surface-labeled BCR 
remaining at the surface of SLO-treated B-cells, compared to ~10% of surface-
labeled BCR at the surface of untreated B-cells (Fig. 2.5 F). 
 Taken together, our data demonstrate that the SLO-wounding and plasma 





Repair of plasma membrane wounding leads to segregation of surface BCRs 
from lipid rafts.    
The inhibitory effect of SLO-mediated injury on the co-clustering of surface BCRs 
with CTB suggests that the plasma membrane repair process prevents surface BCRs 
from interacting with lipid rafts. To investigate this hypothesis, we analyzed the co-
localization between surface-labeled BCRs and CTB using live cell imaging by 
confocal fluorescence microscopy. B-cells that were not treated with SLO but were 
activated by cross-linking for 10 min showed internalization of surface labeled BCRs 
and co-localization of CTB with BCR-containing vesicles (Fig. 2.6, A, C). In 
contrast, there was limited co-localization between internalized BCRs and CTB in B-
cells that were injured by SLO (Fig. 2.6, A, C). We generated kymographs from 
time-lapse images to track the co-localization of the BCR with CTB during BCR 
internalization (Fig. 2.6 B). The kymographs showed continuous co-localization 
between BCRs and CTB during their endocytosis and movement into the cytoplasm 
of B-cells not injured by SLO. In contrast, in B-cells injured by SLO, internalized 
BCRs did not co-localize with CTB (Fig. 2.6 B), indicating a segregation of BCRs 
from lipid rafts during BCR internalization. 
 We further confirmed this result using immunoelectron microscopy, where 
surface BCRs were labeled by 18 nm gold particles and CTB by 10 nm gold particles. 
The co-localization of BCRs with CTB was quantified in individual cells by 
determining the percentage of CTB gold particles in intracellular vesicles that 







Fig. 2.6. Membrane injury by SLO segregates BCRs from CTB-labeled lipid raft 
at the cell surface and during BCR internalization. (A-C) Live cell imaging 
analysis of BCR and CTB internalization. B cells were incubated at 4oC with Alexa 
Fluor 546 F(ab’)2 goat anti-mouse IgM and Alexa Fluor 488 CTB. Time lapse images 
were acquired at 37˚C for 10 min in the presence or absence of SLO using a confocal 
microscope. Shown are representative images at 10 min (A), a kymograph generated 
from time lapse images (B), the average correlation coefficients (±SD) of BCR and 
CTB staining at 10 min (C) from three independent experiments. Scale bar, 2.5 µm. 
(D-G) ImmunoEM analysis of BCRs and CTB in B cells treated with or without SLO. 
B cells were incubated with gold-anti-mouse IgM (18 nm), biotin-CTB plus gold-
strepavidin (10 nm) at 4oC and then incubated with or without SLO at 37˚C for 1 or 5 
min. The percentages of CTB gold particles internalized into vesicles containing BCR 
gold particles at 5 min (D-E) and in the vicinity (<30 nm) of BCR gold particles at the 
plasma membrane (F-G) in individual cells were determined. Shown are 
representative images (scale bar, 100 nm) and the average percentage from ≥16 








microscopy, SLO treatment significantly reduced the percentage of CTB gold 
particles that co-localized with internalized BCRs at 5 min (Fig. 2.6, D-E). In SLO-
treated cells, CTB appeared to accumulate in smaller vesicles that did not contain 
BCR (Fig. 2.6 D). To determine whether CTB is segregated from BCRs at the cell 
surface or during endocytosis, we determined the percentage of CTB gold particles in 
the close vicinity of BCR gold particles on the plasma membrane using 
immunoelectron microscopy. Our results showed that SLO treatment significantly 
reduces the percentage of CTB gold particles localized close to BCR gold particles on 
the B-cell surface, from ~75% and ~60% to ~25% at 1 and 5 min, respectively (Fig. 
2.6, F-G). Our data demonstrate a clear segregation between BCRs and lipid rafts at 
the plasma membrane of B-cells wounded by SLO. Considering that these assays 
were performed under conditions permissive for resealing (in the presence of Ca2+), 
we conclude that endocytosis-mediated removal of plasma membrane wounds 
interferes with the lipid raft-mediated internalization of BCRs.  
The segregation of BCRs from CTB during endocytosis suggests that the BCR 
and CTB are endocytosed into different vesicles. To test this hypothesis, we 
examined the morphology of vesicles where BCRs and CTB that were just 
endocytosed (5 min) were located using immunogold staining and TEM. We found 
that there was a significant increase in the number of tubular-shaped vesicles in SLO 
wounded B-cells, compared to unwounded B-cells (Fig. 2.7, A-B). Based on their 
morphology, we divided vesicles roughly into four categories: small (<120 nm 
diameter), medium (120-250 nm), large (>250 nm), and tubular vesicles (200-500 




in each category by visual inspection. We found that without SLO-induced wounds, 
CTB gold particles were primarily concentrated in small vesicles in unstimulated B-
cells after a 5 min incubation (Fig. 2.7 C). BCR cross-linking did not significantly 
change the intracellular distribution of endocytosed CTB. In SLO-wounded B-cells, 
the percentage of CTB-containing small vesicles was significantly reduced, while the 
percentage of CTB-containing tubular vesicles was significantly increased (Fig. 2.7 
C). Furthermore, BCR cross-linking reduced the percentage of CTB-containing 
tubular vesicles and increased CTB-containing small vesicles in SLO-wounded B-
cells, compared to unstimulated SLO-wounded B-cells (Fig. 2.7 C). This result 
suggests that the SLO-induced CTB redistribution was partially reversed by BCR 
cross-linking. Similar to CTB in unwounded B-cells, BCRs were preferentially 
localized in small vesicles after 5 min incubation in unwounded B-cells (Fig. 2.7 D). 
In contrast to CTB distribution in SLO-wounded B-cells, SLO-triggered wounding 
and repair did not significantly change the preferential location of endocytosed BCRs 
in small vesicles (Fig. 2.7 D). These data suggest that plasma membrane wounding 
and repair induce endocytosis of lipid rafts thorough tubular-shaped vesicles, which 
















Fig. 2.7. Repair of plasma membrane wounds induces CTB endocytosis into 
tubular-shaped vesicles. B cells were incubated with gold-anti-mouse IgM (18 nm), 
biotin-CTB plus gold-streptavidin (10 nm) at 4oC and then incubated with or without 
SLO at 37˚C for 5 min. (A) Representative TEM images of the classifications of 
vesicle morphologies. Scale bar, 100 nm. (B) The average number of tubular-shaped 
vesicles per cell countered by visual inspection. (C) The average percentages of 
individual type of vesicles among all CTB-containing vesicles per cell.  (D) The 
average percentages of individual type of vesicles among all BCR-containing vesicles 
per cell. The data were generated from ≥18 individual cells from two individual 






















This study aimed to investigate whether and how lymphocytes repair plasma 
membrane wounds, and the influence of a putative repair process on B-cell activation. 
Our results demonstrate that primary mouse B-lymphocytes can rapidly repair plasma 
membrane wounds caused by the bacterial pore-forming toxin SLO. We found that 
this B-cell repair process involves lysosomal secretion triggered by Ca2+ influx 
through the wounds, similar to what was previously reported for muscle, fibroblasts 
and epithelial cells (143, 158). Importantly, our results also showed that antigenic 
activation of B-cells, which activates signaling and internalization of the BCR, 
interferes with the plasma membrane repair capability of B-cells. Conversely, the 
plasma membrane repair process suppresses B-cell activation by inhibiting the signal 
transduction and antigen uptake functions of the BCR. As BCR signaling and 
internalization require lipid rafts (164, 165), the mutual suppression between BCR 
activation and plasma membrane repair observed in this study uncovers a critical role 
of lipid rafts in B-cell plasma membrane repair. 
This study suggests that B-cells repair repair wounds on their plasma 
membrane using mechanisms that have several elements in common with those 
reported for muscle, fibroblasts and epithelial cells: rapid lysosomal exocytosis 
followed by endocytosis (157, 158). Exocytosis of lysosomes in wounded B-cells was 
determined by surface detection of the lysosomal membrane protein LIMP2, and 
release of the lysosomal enzyme ASM into the culture medium. Wounding with SLO 
also triggered endocytosis of the fluid phase tracer dextran, a process that was 




exocytosis was inhibited. ASM-induced endocytosis was previously shown to be 
critical for plasma membrane repair by internalizing damaged membrane (143, 157, 
159). Also similar to other cell types (143, 157, 159), inhibition of ASM reduced the 
ability of B-cells able to repair their plasma membrane. However, B-cells from ASM 
knockout mice showed only a moderate reduction in their capability of repairing 
SLO-induced wounds, suggesting that other factors, possibly released by lysosomal 
exocytosis, are required for efficient B-cell plasma membrane repair. Alternatively, 
ASM gene deletion in mice may have enhanced the expression of compensatory 
factors. 
Corrotte et al. have recently reported that caveolae-mediated endocytosis 
mediates the repair of wounds caused by SLO and mechanical forces, in muscle fibers 
and other cell types such as epithelial cells (158). Caveolin is a membrane-associated 
protein that inserts its lipidated hydrophobic domain into the inner leaflet of lipid raft 
regions of the plasma membrane, which are dynamic microdomains rich in 
cholesterol and sphingolipids, such as sphingomyelin and ceramide (175, 196). 
Caveolae are responsible for endocytosis of proteins associated with lipid rafts (196). 
However, lymphocytes do not express detectable amounts of the three known 
isoforms of caveolin (176, 197-199), indicating that endocytosis of plasma membrane 
wounds in B-cells occurs through a mechanism independent from conventional 
caveolins. Furthermore, using TEM, we did not observe a significant accumulation of 
vesicles resembling classical caveolae (~80 nm diameter with flask- or omega-shaped 
plasma membrane invaginations) (176) in B-cells immediately following wounding, 




further supports a lack of caveolin expression in B-cells, since when wounded these 
cells do not show the marked accumulation of plasma membrane-proximal caveolae 
observed in muscle fibers and other cell types (158). However, we cannot completely 
exclude the possibility that an unknown caveolin homologue is expressed in B-cells, a 
possibility supported by our observation that a caveolin-1 specific antibody 
recognizes a protein of higher molecular weight than caveolin-1 in B-cell lysates 
(data not shown).  
Our studies strongly suggest that wounding-induced endocytosis in B-cells is 
lipid raft-dependent, despite the absence of caveolin. This conclusion is supported by 
our findings that wounding induces the rapid endocytosis of lipid rafts labeled by 
CTB, and that perturbing lipid rafts by BCR activation inhibits plasma membrane 
repair. B-cells are known to be capable of endocytosing raft-associated proteins. 
While BCR endocytosis is primarily mediated by clathrin-dependent vesicles, it 
requires lipid rafts as well as actin reorganization (86). Lipid rafts provide the 
platform for clathrin to gain phosphorylation and access to endocytosing BCRs, and 
actin remodeling is required for the fission of clathrin-coated membrane invaginations 
(85, 93, 96). BCRs also have also been reported to be endocytosed via a clathrin-
independent but actin- and raft-dependent pathway in cells with a conditional 
deficiency of the clathrin heavy chain (86). Collectively, these data support the notion 
that B-cells can endocytose wounded plasma membrane via lipid rafts, independent of 
both clathrin and caveolin. 
These observations raise the question of how endocytosis of lipid rafts 




clathrin and caveolin. In wounded muscle fibers, epithelial cells and fibroblasts, 
caveolae-mediated endocytosis of wounded plasma membrane is induced by 
extracellular ASM, released through lysosomal exocytosis (143, 158). ASM converts 
sphingomyelin into ceramide, creating ceramide-enriched membrane microdomains 
that can trigger invagination of lipid bilayers (200, 201). Here we showed that 
wound-induced endocytosis in B-cells is also dependent on extracellular ASM, in the 
absence of caveolin. Furthermore, in wounded B-cells, raft-binding CTB is primarily 
endocytosed into vesicles with a distinct tubular morphology. While the tubular 
vesicles still connected to the plasma membrane observed in SLO-wounded B-cells 
might be considered somewhat similar to caveolae morphologically, their numbers 
are much lower than what is seen in wounded muscle and other cell types. However, 
the number of tubular vesicles increases after B-cell wounding and repair, compared 
to non-wounded B-cells. Together, these results suggest that extracellular ASM 
delivered by lysosomal exocytosis can induce lipid raft endocytosis independent of 
caveolin and clathrin - further supporting the notion that an accumulation of ceramide 
in the plasma membrane due to ASM leads to endocytosis. In the case of B-cells, 
actin remodeling may further facilitate ceramide-induced endocytosis. 
Lipid rafts are critical for both BCR signaling and antigen uptake, two events 
that are essential for B-cell activation. Binding of antigen to the BCR induces 
receptor aggregation in lipid rafts, shown here as co-clustering of BCRs with CTB on 
the cell surface. The clustered BCRs are then phosphorylated by raft-resident Src 
kinases, initiating signaling cascades required for B-cell activation. As we discussed 




the question of whether plasma membrane repair, a process shown in other cell types 
to require lipid raft membrane domains in the form of caveolar endocytosis (158), 
affects BCR activation/signaling/internalization. We found that plasma membrane 
repair and BCR signaling and internalization suppress one another, most likely by 
competing for lipid raft domains on the plasma membrane. Plasma membrane repair 
inhibits BCR signaling and endocytosis via segregation of BCRs from lipid rafts on 
the cell surface, and during endocytosis. Segregation of BCRs from lipid rafts can 
reduce BCR phosphorylation by Src kinases required for intiating signaling (164), 
and inhibit clathrin phosphorylation (85) or interaction with BCR aggregates. We 
found that BCRs and raft-bound CTB not only fail to co-localize at the cell surface 
and during endocytosis, but are also endocytosed in different types of vesicles, small 
and flask-shaped/tubular respectively, in wounded and resealed B-cells. These 
findings indicate that plasma membrane repair interferes with the interactions of 
BCRs with lipid rafts, generating distinct endocytic pathways that compete with each 
other. It is unclear why the two processes do not share lipid rafts. We can speculate 
that this competition may be due to different requirements of the two processes for 
lipid rafts. The formation of BCR signalosomes and endocytosis hot spots may 
require larger and more stable lipid rafts, when compared to the internalization of 
wounded plasma membrane. As shown here and previously, the majority of CTB 
staining on the plasma membrane co-localizes with surface BCRs oo one pole of a 
stimulated B-cell (116). In addition, wounding-induced endocytosis involves a much 




endocytosis (minutes) (138). The mutual suppression further supports the critical role 
of lipid raft domains in both plasma membrane repair and BCR activation.    
We were unable to examine the repair of membrane wounds provoked by 
mechanical forces in B-cells due to their their high vulnerability to shearing force. 
While mechanical wounding causes a form of membrane damage that is presumed to 
be different from SLO, which forms small pores after binding to cholesterol, a 
previous study showed that the repair of both types of membrane wounds are 
mediated via ASM-induced endocytosis (158). This suggests that in B-cells the repair 
of SLO pores and mechanical wounds may also involve local generation of ceramide 
from sphingomyelin and the rapid endocytosis of lipid raft portions of the plasma 
membrane, a process that is functionally equivalent to the caveolar endocytosis 
described in muscle fibers and other cell types. This hypothesis remains to be tested.   
While B-cell membrane damage has not yet been studied in vivo, these cells 
are frequently in an environment that is likely to cause plasma membrane wounding. 
In their lifetime, B-cells circulate through narrow blood vessels at high velocity, 
undergo chemotaxis from blood vessels to infection sites, and migrate through 
lymphatic organs, an extremely crowded environment. It has been shown that when 
B-cells present antigen to T cells or other B-cells, fragments of their plasma 
membrane can be extracted with the antigen by antigen-acquiring cells (84, 170, 202). 
We showed here that B-cells possess a rapid, Ca2+-dependent plasma membrane 
repair mechanism that protects them from wounding-induced death. Importantly, we 
also identified an inhibitory effect of the membrane repair process on BCR activation, 




presenting antigen and while migrating through narrow spaces. While the 
physiological significance of this phenomenon remains to be defined, reductions in 
BCR signaling and antigen uptake may enable them to become better antigen-
presenting cells to other B-cells, or facilitate their progress onto the next stage of 
activation and differentiation in response to T-cell help. Marginal zone B-cells, a 
subset of mature B-cells, are highly mobile, transporting antigens from the marginal 
zone to secluded regions of B-cell follicles in the secondary lymph organs (23). Our 
results raise speculation that the inhibitory effects of B-cell plasma membrane 
damage, possibly provoked by migration and antigen presentation, may sacrifice the 
activation and antigen-uptake activities of marginal zone B- cells in order to support 
the activation of other B- cells, by collecting, transporting, and presenting antigen to 
them. While this hypothesis remains to be tested, our results provide a potential 




































Figure 2.8 Working Model of lipid raft competition between membrane repair 
and BCR activation.  
Lipid raft distribution during BCR activation-  
1. As BCRs bind antigen and aggregate together, they translocate to lipid rafts and 
begin signaling. 
2. BCRs in lipid rafts continue to signal and cluster together to form a central BCR 
cluster for amplified signaling, including recruitment and activation of molecules for 
internalization. 
3. BCR/antigen complexes are internalized and processed for antigen presentation to 
T cells. 
4.  The acquisition of lipid rafts by activated BCRs for signaling and internalization 
inhibits membrane repair, which uses a lipid raft-dependent internalization 
mechanism. 
Lipid raft distribution during membrane repair: 
A. Membrane damage caused by SLO pores allows calcium to enter the cell. 
B. The increase of intracellular calcium induces lysosomal exocytosis, allowing the 
release of acid sphingomyeline (ASM), which induces membrane curvature and 
internalization. 
C.  Lipid rafts are internalized for membrane repair, likely by removing the 
membrane lesion from the cell surface. 
D. During BCR activation, the membrane repair pathway may take lipid raft from 
BCRs 
E. As lipid raft is used for membrane repair, BCR clustering and signaling, and 





Chapter 3: Regulation of the early events of B cell activation 
by the density and valency of membrane-associated antigen 
3.1 Abstract  
 
The immunogenicity of immunogens is the key to the efficacy of vaccines and can be 
manipulated via the chemical and physical properties of the immunogen. In vivo, the 
majority of antigens encountered by B cells are presented on membranes. Membrane-
associated antigens have been shown to be more efficient than soluble antigens to 
activate B cells. Antigens initiate B cell activation by binding to B cell receptors 
(BCRs) that induce signaling cascades. However, how the properties of membrane 
bound antigens regulate BCR activation is not fully understood. This study 
investigated the role of density and valency of membrane bound antigen on the early 
events of BCR activation, including actin-driven BCR clustering and B cell 
spreading. We have generated a new antigen system that provides optimal orientation 
on planar lipid bilayers for binding to the BCR and enables alteration of densities and 
valencies of the antigen. Using interference reflection and total internal reflection 
fluorescence microscopy, we found that the levels of B cell spreading, BCR self-
clustering, and protein tyrosine phosphorylation are increased as the density of 
antigen increases. However, stimulation of B cells with bivalent versus monovalent 
antigens on membranes with the same density does not result in any difference in B 
cell spreading, antigen accumulation, and protein tyrosine phosphorylation. Live cell 
imaging analysis of B cells from Lifeact transgenic mice showed that higher antigen 




BCR clustering. Our results demonstrate that differing from soluble antigen, the 
density, but not the valency, of membrane bound antigen is critical to BCR activation. 
Antigen density regulates BCR activation by modulating actin-mediated B cell 
spreading and antigen accumulation. The method established in this study for creating 
optimally oriented antigen and the density of membrane bound antigen provide an 
important tool for studies of B cell activation in vitro and optimization of vaccine 
design. 
3.2 Introduction 
The humoral immune system consists of B cells that produce antibody and provide 
humoral immunological memory for protection against invading pathogens. B cells 
are activated by antigens that bind their specific B cell receptors (BCR). The majority 
of antigens that B cells encounter in vivo are presented on the membranes of other 
cells, such as marginal zone B cells, macrophages, and follicular dendritic cells (23). 
BCR binding to membrane bound antigen induces BCR clustering and B cell 
spreading over the target membrane. This increases the contact area between B cells 
and the target membrane. B cell spreading increases the number of BCRs that bind to 
antigen and the number of BCR clusters at the leading edges of the spreading B cell 
membrane. BCR self-clustering is required for initiating signaling. After reaching its 
maximal spreading, the B cell then contracts, reducing its contact area with the target 
membrane. B cell contraction drives the coalescence of BCR microclusters into a 





B cell spreading, BCR clustering, and central cluster formation require 
remodeling of the actin cytoskeleton. Actin inhibitors obliterate all of these events, 
consequently suppressing BCR signaling and B cell activation (60-62). Upon BCR 
engagement, there is a transient depolymerization of cortical actin, allowing for free 
later diffusion of surface BCRs and the formation of nano-scale BCR clusters (60, 65, 
66). BCR clustering activates signaling, leading to actin reassembly at BCR clusters 
(61, 67). As BCR clustering and signaling continues, actin concentrates at the leading 
edges of the spreading B cell membrane. When maximal spreading is reached, actin 
forms a ring-like structure around BCR clusters, which is required for cell contraction 
and central cluster formation (61, 64).  
Properties of antigens can modulate B cell activation, thereby becoming an 
important target for vaccine design. Previous studies have demonstrated that the 
affinity, valency, or concentration of soluble antigen enhance BCR aggregation and 
signaling (25, 80, 116). Similarly, increasing affinity or density of membrane bound 
antigen induces greater B cell spreading, BCR clustering, and BCR signaling, 
however, the role of antigen density on actin dynamics is unknown, even though actin 
dynamics are crucial for inducing B cell spreading and BCR clustering and signaling 
(60-62, 64). The density of membrane bound antigen appears to be able to overcome 
the lower affinity of the antigens in activation of B cells (64). For vaccine design, the 
density of an antigen is much easier to manipulate than affinity or valency. Although 
the role of antigen density on BCR activation is becoming clear, how to identify the 
optimal antigen density and how exactly antigen density regulates BCR activation 




In the secondary lymphoid organs, B cells can encounter antigens in both 
soluble and membrane bound forms. Recent studies have shown that most of antigen 
have been shuffled by marginal zone macrophages and B cells into B cell follicles 
and presented by follicular dendritic cells. For soluble antigen, multi-valencies are 
critical to its immunogenicity as only multi-valent soluble antigen can cross-link 
BCRs into oligomers, which is required to trigger signaling as well as efficient 
antigen internalization and presentation to T cells (23, 110, 115). For membrane 
bound antigen, monovalent antigen has been shown to be capable of inducing B cell 
spreading and BCR clustering and signaling (68). However, whether the valency of 
membrane bound antigen has any effect on BCR activation and how the density of 
membrane bound antigen regulates BCR activation are not fully understood.  
A lack of well-defined antigenic stimulatory systems has hindered our 
understanding of how antigen density and valency influence BCR activation. Current 
membrane bound antigen systems use (4-Hydroxy-3-Nitrophenyl)Acetyl (NP)-BSA 
and biotinylated Fab2. NP-BSA is made by reaction of the succinic anhydride ester of 
NP to amines of BSA. The NP-BSA is attached to a histidine tag so that they may 
bind to nickel labeled lipid bilayers. The exact number of NPs conjugated to a BSA is 
unknown and thus the valency is unknown, plus the location of the histidine tag is 
random and there is no way of knowing if all the NPs on the BSA is accessible to 
BCRs (68, 203, 204). Similarly, the biotinylation site of the Fab2 is unknown and 
when added to streptavidin coated lipid bilayers, the BCR binding site may not be 




To address these questions, we have designed a novel antigen system, which 
was designed to generate optimized and homogenous orientation of membrane bound 
antigen to bind BCRs. This model antigen system allows us to define the density and 
valency of antigen on membranes, thereby studying their effects on BCR activation. 
Using this model antigen system combining live-cell imaging with interference 
reflection (IRM) and total internal reflection fluorescence microscopy (TIRF) of 
primary B cells from mice expressing LifeAct-GFP transgene, we examined the 
effects of density and valency of membrane bound antigen on the early events of 
BCR activation. Our results show that the maximal levels of B-cell spreading, BCR 
clustering and signaling in the contact zone are antigen-density dependent. Increased 
B cell spreading is associated with rapid accumulation of F-actin behind spreading 
membrane, and amplified BCR clustering is linked to faster growth of BCR 
microclusters. However, the valency of membrane bound antigen had no effect on B-
cell spreading, antigen accumulation, and tyrosine phosphorylation. These results 
show that this model antigen system is useful for studying mechanisms underlying 
BCR activation and for optimizing immunogen complexes, such as antigen 
incorporated liposomes, for vaccine development.       
 
3.3 Materials and Methods 
Mice and B cell isolation 
Splenic B cells were isolated from wild-type (C57BL/6) (Jackson Laboratories), 
transgenic MD4 mice (Jackson Laboratories), and Lifeact mice of C57BL/6 




gradient centrifugation (Sigma-Aldrich). T cells were depleted by anti-Thy1.2 mAb 
(BD Biosciences) and guinea pig complement (Rockland Immunochemicals), and 
monocytes were removed by panning for 1 hour. All procedures involving mice were 
approved by the Institutional Animal Care and Usage Committee of the University of 
Maryland.  
 
Antibodies and reagents 
For intracellular staining, cells were fixed with 4% PFA and permeabilized with 
0.05% saponin and incubated for 30 min with anti-phosphotyrosine antibody (clone: 
4G10) (Millipore), followed by 30 min with Alexa Fluor 488 goat anti-mouse IgG2b 
(Invitrogen) for BCR signaling staining. 
 
Biotinylation of antigens 
To produce the monobiotinylated goat anti-mouse IgM and IgG Fab’ (bFab), a 
published protocol (207) was followed. Briefly, the disulfide bonds of Fab2’ 
fragments (Jackson Immunoresearch) were reduced by 2-Mercaptoethylamine 
(Thermo Scientific) and the resulting sulfhydryls were then biotinylated with 
Maleimide-PEG2-Biotin (Thermo Scientific). EZ Biotin quantitation kit (Pierce 
Protein) was used for the determination of a 1:1 ratio of biotin to Fab’. The bFab was 
then labeled with Alexa Fluor 546 (Invitrogen). 
 
Hen egg lysozyme (HEL) (Sigma) was biotinylated with NHS-PEG4-Biotin (Thermo 




biotinylate the N-terminus and thus not likely to block the epitope for BCRs of MD4 
mice (208). EZ Biotin quantitation kit (Pierce Protein) was used for the determination 
of a 1:1 ratio of biotin to HEL. The biotinylated HEL (bHEL) was then labeled with 
Alexa Fluor 546 (Invitrogen). 
 
Preparation of antigen bound artificial membranes 
An established protocol described previously was used for making planar lipid 
bilayers (44, 209). Briefly, 1,2-dioleoyl-sn-glycero-3-phosphocholine and 1,2-
dioleoyl-sn-glycero-3-phosphoethanolamine-cap-biotin (Avanti Polar Lipids, 
Alabaster, AL) at a 100:1 molar ratio in PBS (total concentration of 5 mM) was 
sonicated to form liposomes, that were then centrifuged and filtered to get rid of any 
aggregates. Liposomes were added to glass coverslip chambers (Nunc lab-tek) and 
incubated for 10 min., after which each well was washed with 20 ml PBS. Next 1 
μg/ml of streptavidin (Jackson ImmunoResearch Laboratories) was incubated on the 
planar lipid bilayer coated coverslip for 10 min and washed with PBS. Lastly, the 
biotinylated antigen was allowed to incubate on the coated coverslip for 10 min and 
then washed with PBS. For experiments using bFab or bHEL on the lipid bilayer, 1 
µg/ml of AF546 bFab or AF546 bHEL was used and non-fluorescent bFab or bHEL 
was added to make up to the total concentration used.  
 
For experiments testing different concentrations of streptavidin on the lipid bilayer, 
WT or MD4 B cells were labeled with 5 µg/ml AF546 bFab or 5 µg/ml AF546 bHEL 






TIRFM and IRM images were taken with a Nikon laser TIRF system on an inverted 
microscope (Nikon TE2000-PFS), equipped with a 60×, NA 1.49 Apochromat TIRF 
objective (Nikon Instruments, Melville, NY), a Coolsnap HQ2 charge-coupled device 
camera (Roper Scientific, Sarasota, FL), and two solid-state lasers of wavelengths 
491 and 561 nm. For live cell imaging, time lapse images were taken at the rate of 
one frame every 2 sec. 
 
Imaging and statistical analysis 
Andor iQ software (Andor Technology, Belfast, U.K.) was used to analyze the mean 
fluorescence intensity line profiles of cells and the fluorescence intensities in the B 
cell contact area. The B cell contact area was determined from interference reflection 
microscopy (IRM) images and was analyzed using custom Matlab programs 
(MathWorks, Natick, MA). BCR cluster tracking was performed using the MATLAB 
(Mathworks, Natick, MA) image analysis package uTrack version 2.1.3 
(http://lccb.hms.harvard.edu/software.html) (210). Postprocessing of tracked data was 
performed with custom programs in MATLAB. At least 30 cells per condition were 
analyzed for fixed cells and at least 15 cells per condition were analyzed for live 
imaging. 





Design of membrane-bound antigen with homogenous and optimized orientation 
In order to definably measure the effects of antigen density and valency on B cell 
activation, we modified a method described by Peluso et al. (207) to generate  
monobiotinylated Fab’ fragment (mB-Fab’) from F(ab’)2 fragment of antibody and 
tether it onto a streptavidin-coated surface as a microarray to quantify cytokines. We 
adapted this method to generate mB-Fab’ fragment of antibody specific for mouse Ig, 
a component of the BCR, tethered to planar lipid bilayers. Similar to the published 
method, we use streptavidin as the linker to hold the mB-Fab’ to the lipid bilayer 
containing biotinylated phospholipid (63). To generate the mB–Fab’ from F(ab’)2-
anti-mouse IgG+M,  the disulfide bond that links the two Fab’ fragments were 
disrupted using a reducing reagent, 2-mercaptoethylamine. Since all other disulfide 
bonds remain intact, this reducing reaction generates single sulfhydryl groups at the 
C-terminal region of each Fab’ fragment. The sulfhydryl was then biotinylated with 
Maleimide-PEG2-Biotin and labeled with Alexa Fluor 546 (Fig. 3.1 A). The binding 
of the biotin at the C-terminal region to lipid bilayers exposes the antigen binding site 
at the N-terminus, allowing Fab’ to bind to mIg of the BCR. As all Fab’ only has 
single biotin at the same cysteine, all mB-Fab’ tethered to lipid bilayers will exhibit 
same orientation and binding ability to BCRs.   
To determine whether mB-Fab’-anti-Ig stimulated BCRs as a bona fide 
antigen, we used a different stretagy to generate monobiotinylated hen egg lysozyme 
(mB-HEL) using NHS-PEG4-Biotin. This  primary amine-targeted reagent has been 





Fig. 3.1: Design of antigen presenting membranes with optimally oriented 
antigen. (A) To produce monobiotinylated goat anti-mouse IgM and IgG Fab’ 
(bFab), the disulfide bonds of F(ab’)2 fragments were reduced by 2-
Mercaptoethylamine (MEA) and the resulting sulfhydryls were biotinylated with 
Maleimide-PEG2-Biotin (MPB). The mB-Fab was then labeled with Alexa Fluor 546 
(AF546). Oriented membrane bound antigen was made by coating coverslip 
chambers with biotinylated lipid, followed by streptavidin, and lastly mB-Fab. (B) 
Hen egg lysozyme (HEL) was biotinylated with NHS-PEG4-Biotin (NPB), which 
reacts with primary amines and for HEL this predominantly biotinylates the N-
terminus and thus not likely to block the epitope for BCRs of MD4 mice. The 
biotinylated HEL (mB-HEL) was then labeled with AF 546. The same protocol for 
making oriented membrane bound mB-Fab was used for mB-HEL. 
  








the binding epitope for BCRs of B cells from MD4 mice (208). Similarly, the mB- 
HEL was then labeled with Alexa Fluor 546 (Fig. 3.1 B).        
Monobiotinylation of Fab’ and HEL was confirmed by measuring the 
concentration of both proteins and biotin using Pierce Protein’s EZ Biotin 
quantitation kit,  ascertaining a 1:1 ratio of biotin to Fab’ or HEL. We also removed 
F(ab’)2 that remained as residues of the reducing reaction using centrifugal filter with 
a molecular weight cutoff 100 kDa, and the purity was confirmed by  Western Blot 
(Fig 3.2 A). The purity of mB-Fab’ was also determined biologically by its 
incapability of clustering BCRs in the absence of streptavidin. B cells from WT and 
MD4 mice were first labeled with Alexa Fluor (AF) 546-conjugated mB-Fab’ and 
mB-HEL, respectfully, followed by with or without streptavidin to cross-link bAgs. 
Only B cells with streptavidin treatment had significant percentages of B cells 
exhibiting polarized clustering of BCRs to one pole of the cell, called BCR capping. 
Few B cells showed BCR caps in the absence of streptavidin (Fig.3.2 B). 
Furthermore, the percentage of B cells showing BCR capping increased as the 
concentration of streptavidin increased (Fig 3.2 C). These results demonstrate that the 
generated model Ags are monovalent and monobiotinylated, and after binding to 
BCRs, their conjugated biotin is readily available for streptavidin to bind. 
 
B cell spreading, BCR clustering and signaling increase as the density of the 
membrane-bound antigen increases 
Using the established model antigen system, we examined the effects of membrane 





Fig. 3.2: Confirmation of monobiotinylated, monovalent antigen. (A) Western 
blot for biotin showing that the majority of biotinylated sample is Fab. (B) Testing 
monobiotinylation and monovalency of antigen by examining the percentage of BCR 
capping when streptavidin is added to cross-link the mB-Ag (bAg). WT and MD4 B 
cells were labeled with mB-Fab and mB-HEL respectfully, for 30 min at 4˚C. 
Samples were then incubated with streptavidin for 10 min at 4˚C, warmed to 37˚C, 
and fixed at 5 min. Cells were imaged using fluorescence confocal microscopy and 
the percentage of capped cells were compared between with and without streptavidin. 
(C) The percentage of capped B cells was determined for increasing the concentration 
of streptavidin with mB-Fab labeled cells. Scale bar 2.5 µm. Shown is the mean of 




density in two different ways. In the first way, we labeled surface BCRs with AF546-
mB-Fab’-anti-Ig or AF546-mB-HEL first and let the B cells to interact with lipid 
bilayers coated with varying densities of streptavidin (1, 2, 4, 8 nM). This method 
allowed us to track BCR clustering. Similar to the results with soluble streptavidin, B 
cells only spread and formed clusters on lipid bilayers teathered with streptavidin. 
Using the 5-min time point when B cell spreading reached nearly maximal, we found 
that the B cell contact area and both the mean (MFI) and total fluorescence intensity 
(TFI) of AF546-Fab’-anti-Ig- or AF546-HEL-labeled BCRs in the contact zone were 
increased in a proportional fashion as the concentration of streptavidin, indicating 
streptavidin-dependent enhancement of B cell spreading and BCR clustering at 5 min 
(Fig. 3.3 A, B). Next, we evaluated the overall signaling level induced by the BCR 
using phosphotyrosine (pY) staining. The TFI of pY increased dramatically as the 
density of streptavidin on lipid bilayers, however, the MFI of pY no longer increased 
when the concentration of streptavidin reached beyond 4 nM, even though the B cell 
contact area and the MFI of BCRs in the contact zone continuously increased, 
suggesting when BCR clustering reaches a certain level, it cannot enhance signaling 
further (Fig. 3.3 C). These results demonstrate that both mB-Fab’-anti-Ig and mB-
HEL are effective in stimulating BCRs as membrane bound antigen, and increasing 
density of streptavidin as cross-linkers proportionally increases B cell spreading, 
BCR clustering, and enhances BCR signaling. 
The second way we changed the antigen density was by varying the amount of 
mB-Fab’-anti-Ig and mB-HEL to lipid bilayers (20, 60, 120 nM) while keeping the 







Fig. 3.3: Effects of antigen density on planar lipid bilayers on B cell spreading, 
BCR clustering, and BCR signaling by changing streptavidin concentration. B 
cells were labeled with AF546 bFab for 30 min at 4˚C before stimulation for 5 min at 
37˚C with varying concentrations of streptavidin on lipid bilayers (A) Representative 
images using IRM and TIRFM of Alex Fluor 546 mB-Fab labeled B cells at 5 min 
time points on lipid bilayers containing increasing concentrations of streptavidin; and 
corresponding quantification of the B cell contact area and BCR mean fluorescence 
intensities. (B). Same as B, but testing AF546 mB-HEL with MD4 B cells. MD4 B 
cells were labeled with AF546 mB-HEL for 30 min at 4˚C and stimulated with 
varying densities of streptavidin tethered to lipid bilayers at 37˚C and fixed at 5 min 
time points. The samples were then permeabilized and stained for phosphotyrosine. 
(C) Representative IRM and TIRFM images showing phosphotyrosine distribution of 
Alexa Fluor 546 mB-HEL labeled cells stimulated with increasing concentrations of 
membrane bound streptavidin at 5 min time points; and corresponding quantification 
of the fluorescence intensities of pY in the B cell contact area with increasing 
concentrations of streptavidin for 5 min time points. Scale bars, 5 µm. Shown is the 
mean (±SEM), *P≤0.05, **P≤0.005, ***P≤0.0005, Students T Test. The results are 








contact area and the MFI and TFI of antigen in the contact zone 5 min post 
stimulation.  Similar to the B cell response to varying streptavidin densities, both B 
cell contact area and the MFI and TFI of antigen increased proportionally with 
increasing densities of antigen. These results together indicate that increasing the 
density of antigen on membranes enhances B cell activation (Fig. 3.4). 
To examine the effect of antigen density on the dynamics of B cell spreading 
and BCR clustering, time-lapse images were acquired using IRM and TIRF. Higher 
densities of mB-Fab induced greater levels of B cell spreading and contraction, and 
BCR fluorescence intensity over time in the contact area (Fig. 3.5, A,B). The increase 
of BCR intensity in the contact area correlates with the enhanced BCR intensities of 
individual BCR microclusters tracked over time (Fig. 3.5 C), indicating faster growth 
of BCR clusters. All together, these results suggest that increasing antigen density 
enhances B cell spreading and BCR clustering, which correlates to the intensity of 
individual BCR microclusters that grow and accumulate at the synapse. 
 
Antigen density modulates the level and distribution of the actin cytoskeleton in 
the B cell contact zone 
B cell spreading, BCR clustering and BCR signaling depend on actin dynamics (67, 
70). The effects of antigen density on these signaling events suggest that antigen 
density also influences actin remodeling induced by BCR signaling. We examined 
actin dynamics by live cell images of B cells from mice expressing LifeAct-GFP that 
binds to F-actin, using IRM and TIRFM. B cells were stimulated with varying 








Fig. 3.4: B cell spreading and BCR clustering depends on the density of 
membrane bound antigen. (A) WT B cells were stimulated with the indicated 
densities of membrane bound mB-Fab at 37˚and fixed at 5 min. Shown are 
representative IRM and TIRFM images showing the spreading and BCR clustering of 
B cells stimulated with varying concentrations of mB-Fab tethered to lipid bilayers. 
Scale bar, 5 µm. Graphs to the right show the quantitative analysis of the contact area 
and mean and total fluorescence intensities of  clustered BCR in the B cell contact 
area. (B) MD4 B cells were stimulated with indicated concentrations of mB-HEL 
bound to lipid bilayers at 37˚ and fixed at 5 min. Shown are representative IRM and 
TIRFM images showing the spreading and antigen clustering of MD4 B cells 
stimulated with varying concentrations of mB-HEL tethered to lipid bilayers. Scale 
bar, 5 µm. Graphs to the right show the quantitative  analysis of the contact area and 
mean and total fluorescence intensities of  clustered BCR. Shown is the mean 
(±SEM). *P≤0.05, **P≤0.005, ***P<0.0001, Students T Test. The results are 





















Fig. 3.5: The dynamics of B cell spreading, BCR clustering, and F-actin depends 
on the density of membrane bound antigen. (A) Representative IRM and TIRFM 
images of 5 min time points from live images of Lifeact B cells stimulated with 
increasing concentrations of mB-Fab tethered to lipid bilayers. (B) Analysis of live 
imaging of the contact area and total (integrated) fluorescence intensities of AF546 
mB-Fab and F-actin (Lifeact-GFP) accumulation in the B cell contact area. Verticle 
line marks the time for the peak of B cell spreading. (C) Fluorescence intensities of 
individual BCR microclusters induced by the different densities of antigen. Individual 
BCR microclusters were tracked from their appearance (blue) to their fusion with 
other BCR microclusters (red). Scale bar, 5 µm. Shown is the mean (±SEM). 
***P<0.0001, Students T Test. The results are representative of three independent 
experiments.  
  




acquired 5 sec after dropping the cells onto lipid bilayers. TIRFM showed that for the 
lowest density of antigen (20 nM), B cells did not exhibit redistribution of Lifeact-
GFP, and the MFI of Lifeact-GFP in the contact zone was much lower than those 
cells interacting with higher density of antigen (Fig. 3.5 B; Fig. 3.6 A). To examine 
the spatial relationship of F-actin with spreading membrane, IRM and Lifeact-GFP 
TIRFM images were overlayed.  The results demonstrated that F-actin primarily was 
accumulated at the periphery of the B cell contact area, forming an actin ring, when 
the antigen density was 60 nM and higher, but not when the antigen density was 
reduced to 20 nM (Fig. 3.6 A, B). The greatest F-actin accumulation was seen at sites 
of actively extending membrane during B cell spreading (Fig. 3.6 C). The intensity of 
the actin ring decreased during B cell membrane contraction and the highest mB-Fab 
density induced a greater contraction of the B cells (Fig. 3.5 B; Fig. 3.6 A).  
Measuring the integral of the autocorrelation function of the F-actin fluorescence 
intensity further demonstrated the lack of extension and retraction of membrane when 
stimulated with 20 nM, whereas densities of 60 nM and 120 nM induced high actin 
dynamics at the cell periphery, correlating to movement of the B cell membrane (Fig. 
3.6 D). Overall, these results reveal that a higher density of membrane antigen 
enhances F-actin intensity at the periphery of spreading membranes, which correlates 














Fig. 3.6: F-actin intensity and distribution depends on the density of membrane 
bound mB-Fab. (A) Representative IRM and TIRFM images of 1 and 5 min time 
points from live images of Lifeact B cells stimulated with increasing densities of mB-
Fab. 1 min images demonstrate B cell spreading and F-actin accumulation in 
spreading membranes. 5 min images show B cell membrane contraction and actin 
ring formation on the border of contact area. (B) Mean fluorescence intensity line 
profiles of 1 and 5 min times points revealing distribution of F-actin to periphery of 
contact area. Scale bar,5 µm. The results are representative of three independent 
experiments. (C) IRM and TIRFM images showing high F-actin intensity 
accumulated in actively spreading B cell membrane edges. Arrows point to spreading 
membrane in IRM and dense F-actin intensity in TIRFM image. (D) Integral of the 
autocorrelation function of the F-actin fluorescence intensity of each image pixel 
plotted at the original pixel position. High autocorrelations at the cell periphery 
indicate extensions and retractions of membrane. 
 















We have already shown that greater densities of antigen induce enhanced 
actin dynamics that corresponds to B cell spreading. Actin dynamics are known to 
mediate BCR clustering and synapse formation. We examined the effects of antigen 
density on actin and BCR dynamics in the B cell contact area over time. Looking at 
the fluorescence intensity of BCR clustering over time, it is seen to correlate with 
actin dynamics. The greater F-actin intensities induced by higher densities of antigen 
lead to greater BCR clustering, indicating that BCR clustering correlates with actin 
dynamics (Fig. 3.5 B). Examining the distribution of F-actin and BCR using TIRFM, 
it was seen that the higher densities induced synapse formation, as seen by the actin 
ring formation bordering clustered BCRs in the center of the contact area (Fig. 3.7, A, 
B). The 20 nM density failed to induce BCR clustering and formation of the actin ring 
typically seen bordering the central BCR cluster (Fig. 3.7, A, B). Taken together, 
these results indicate that BCR clustering corresponds to actin dynamics, and both 
depend on antigen density for enhanced intensities in the contact area and distribution 












Fig. 3.7: The density of membrane bound antigen effects BCR clustering via 
actin dynamics (A) Representative IRM and TIRFM images of  5 min time points 
from live images of Lifeact B cells stimulated with increasing concentrations of mB-
Fab tethered to lipid bilayers.  Images demonstrate F-actin ring that borders BCRs to 
form a synapse. (B) Mean fluorescence intensity line profiles of 5 min time point 
images from (A), revealing F-actin distribution to outside of aggregated BCR. Scale 






The B cell response to membrane bound antigen does not depend on the 
antigen’s valency 
 
To determine the role of antigen valency on B cell activation, we developed a 
membrane bound antigen system presenting optimally oriented antigen as either 
monovalent or bivalent (Fig. 3.8 A). Monovalent antigen was made by using a 1:1 
ratio of streptavidin to bFab and bivalent used half the streptavidin concentration at 
a1: 2 ratio. The mean fluorescence intensities were measured to affirm the same 
densities of antigen for both valency systems (Fig. 3.8 B), thus indicating the valency 
of each system is correct. WT primary mouse B cells were stimulated with either 
monovalent or bivalent antigen and B cell spreading, antigen accumulation, and BCR 
signaling was measured to determine differences in B cell activation. Comparing 
monovalent to bivalent, there was no significant differences in B cell activation (Fig. 
3.9). These results demonstrate that the valency of membrane bound antigen does not 






Fig. 3.8: Design of membrane bound valency system. (A) A monovalent membrane 
bound antigen system was developed using a 1:1 mB-Fab to streptavidin ratio, while 
for bivalent, a 2:1 mB-Fab to streptavidin ratio was used with half the streptavidin 
density. (B) Confirmation that the antigen density for both systems was the same, 
indicating that the valency is increased for the bivalent system. The mean 
fluorescence intensities of both systems were taken for comparison using TIRFM. 
Shown is the mean (±SD). The results are representative of three independent 








Figure 3.9: The valency of membrane bound antigen has little effect on B cell 
spreading, antigen clustering, and signaling. WT B cells were stimulated with 
either monovalent or bivalent mB-Fab on lipid bilayers and fixed at 5 min. The 
samples were then permeabilized and stained for pY.  Quantification of IRM and 
TIRFM images of the contact area, mean fluorescence intensity of gathered antigen, 
and mean fluorescence intensity of phosphotyrosine for B cells interacting with either 
monovalent or bivalent antigen on the lipid bilayer. Shown is the mean (±SD). The 












This study addresses the role of antigen properties on B-cell activation. Increasing the 
affinity, valency, or concentration of soluble antigen enhances B cell activation (25, 
80, 116). However, the effects of the properties of membrane bound antigen on B-cell 
activation requires further examination. The majority of antigens in vivo are presented 
to B cells as membrane bound (23), suggesting the importance of studying the effects 
of membrane bound antigen on B-cell activation. Previous studies have shown that 
increasing the density of membrane bound antigen enhances B cell spreading and 
antigen accumulation (64), yet the effects on actin dynamics have not been 
determined and the optimal antigen density for BCR activation and exactly how 
antigen density regulates BCR activation still remains elusive. Plus there are no well-
defined antigenic stimulatory systems to use for studying the effects of antigen 
density and valency on BCR activation. The current membrane bound antigen 
systems have no way of determining the exact antigen density or valency presented to 
BCRs. 
 We developed a novel antigen system to present homogeneous optimally 
oriented antigen on artificial membranes. Using both Fab’ and HEL, we generated 
antigens that were shown to be monovalent and monobiotinylted, thus obtaining 
optimal orientation when added to streptavidin coated biotinylated lipid bilayers. This 
system was demonstrated to be effective for studying the role of density and valency 
of membrane bound antigen on B-cell activation.  
Our system showed that increasing antigen density proportionally increases B 




demonstrated that higher antigen densities enhances actin dynamics, which 
corresponds to greater B cell spreading and BCR clustering. Previous studies from 
my lab have shown that actin distributes to the edges of the spreading membrane and 
then forms a ring around the antigen to form the synapse (61, 73), this was also seen, 
and we further demonstrated the role of antigen density on F-actin intensity and 
distribution. Low antigen density induced decreased actin dynamics, inhibiting B cell 
spreading and BCR clustering. Since spreading was inhibited, F-actin did not 
distribute to the edges of spreading membranes and failed to form a synapse. 
Increasing antigen density enhanced F-actin intensities at the leading edges of the 
spreading membrane and this in turn related to greater B cell spreading and BCR 
clustering. These results coincide with previous studies showing increasing densities 
of membrane antigen enhances B cell spreading and antigen accumulation (64), 
however, our quantification further reveals that the increased B cell activation is 
proportional to the increase in antigen density. Our work further demonstrates the role 
of antigen density on actin dynamics and how this relates to B cell activation.  
In contrast to antigen density, valency had no effect on B cell spreading, 
antigen accumulation, or BCR signaling. This data supports the finding that 
monovalent membrane bound antigen still induces B cell activation due to the 
induced conformational change in the BCR, which initiates BCR oligomerization 
(68). Thus when presented on membranes, the valency of an antigen has little effect 
on increasing BCR clustering and initiating signaling and spreading. 
Our work suggests that density of membrane bound antigen rather then 




as presentation of the same epitope at high density induces enhanced B-cell activation 
on a linear level. The exact density of membrane bound antigen required for efficient 
B-cell activation has not been determined, but we designed a system where this is 
possible to do, thus our model will benefit quantitative studies of the molecular 
mechanisms underlying BCR activation. The results here indicate that manipulations 
of an antigen’s molecular configuration and density can be applied to enhance the 
immunogenicity of vaccines. Overall, we created an antigen system that will be useful 
for examining the mechanism of B cell activation in vivo and which properties and 





















Chapter 4:  Discussion 
 
B cell membrane repair  
Mechanism of Repair 
 
We have demonstrated that B cells repair their plasma membranes in a calcium 
dependent manner. Calcium has been known for decades to be important for 
membrane repair (137-139). The influx of calcium triggers exocytosis of lysosomes 
in epithelial and muscle cells (142-144). This was also seen with B cells after SLO 
treatment, where there was LIMP2 surface staining and detection of ASM in the 
surrounding media. Examining whether ASM is required for B cell membrane repair, 
we discovered using inhibitors and ASM KO mice, that it is important since repair 
decreased, however, ASM KO mice still repair their cells, thus indicating there may 
be other lysosomal proteins that may compensate.  
After lysosomal exocytosis, it has been suggested that the damaged membrane 
is removed from the membrane surface by either blebbing and vesicle shedding or 
endocytosis (156-159). We saw no blebbing during live imaging of B cells during 
SLO treatment or with TEM images; however, there was an increase in 
internalization of the fluid phase endocytic marker, dextran, after SLO treatment. 
Also addition of extracellular SM enhanced B cell membrane repair in the absence of 
calcium after SLO damage, suggesting that inducing internalization alone aids repair. 




lipid raft internalization was increased using CTB as a lipid raft marker. This increase 
in lipid raft internalization correlates with previous work demonstrating that 
cholesterol and caveolin are required for membrane repair of epithelial cells (157, 
158).   
B cells do not express any known form of caveolin (176, 197-199), thus it is 
of interest to examine the types of vesicles the CTB are endocytosed into. Caveolae 
are responsible for endocytosis of proteins associated with lipid rafts (196) and are 
identified in TEM images as ~80 nm diameter with flask- or omega-shaped plasma 
membrane invaginations (176). Examining our TEM images, no such caveolae 
invaginations were observed. Although B cells lack caveolin, they still have lipid raft 
internalization. In fact, BCR internalization requires lipid rafts, actin, and clathrin (85, 
86, 94). B cells have also been shown to have clathrin-independent internalization, 
which depends on lipid rafts and actin dynamics (86). We have demonstrated that 
inhibiting actin polymerization reduces B-cell membrane repair, implying that actin 
remodeling may play a role in one of the steps for membrane repair, which possibly 
could be internalization. Determining whether actin is required for endocytosis for B 
cell membrane repair requires further investigation. 
Examination of CTB positive vesicles revealed that there was an increase of 
the lipid raft into tubular-shaped vesicles. Previous identification of these type of 
structures have been made and are classified as lipid raft-dependent, actin-dependent, 
and clathrin-independent (211). From our TEM images these tubular vesicles do not 
appear to be clathrin-coated. Tubular vesicles are known to form from the B subunit 




and what promotes their formation is unknown (211, 212). For B cell membrane 
repair, these structures may be induced by ASM, which has been demonstrated to 
induce inward curvature of membranes via production of ceramide from 
sphingomyelin (138, 143, 158). Also, as B cells do not express caveolin, the ASM 
induced invagination of lipid raft may not be caught and held into small vesicles at 
the membrane surface, but rather is pushed inward until endocytic molecules are 
recruited from the cytoplasm. This may be investigated by treatment of B cells with 
extracellular SM to see if the same tubular structures are formed. 
Our results have shown that B cells repair in a similar manner as epithelial and 
muscle cells, although with several differences that may be due to lack of caveolin, 
demonstrating a new mechanism for repair. Like epithelial and muscle cells, B cells 
repair in a calcium dependent exocytosis of lysosomes, which releases ASM to the 
plasma membrane surface and induces internalization of lipid rafts. Differing from 
these cells, B cells internalize the lipid rafts into tubular-shaped vesicles; also B cells 
rely on actin reorganization, but whether it is for internalization requires 
investigation. Previous work has shown that epithelial cells do not require actin 
remodeling for membrane repair and that disruption of the actin cytoskeleton actually 
enhanced endocytosis and repair (157, 158). Additionally, epithelial cells do not 
require dynamin for endocytosis for repair (139, 162). Whether the tubular vesicles 
require dynamin for internalization induced B cell repair is not known, however, 
other studies have shown that the tubular vesicles may be dynamin dependent or 




We mapped out a repair mechanism for B cells injured with SLO. SLO binds 
to cholesterol and therefore may alter lipid rafts and modulate membrane repair. 
Hence, it is important to examine B cell membrane repair of mechanical wounding, 
such as scratching. Other studies of mechanical wounding have demonstrated that 
cholesterol and caveolin are required for repair (157, 158), indicating that B cells may 
still repair in a similar mechanism for mechanical wounding.  
 
Effect of membrane repair on B cell activation     
 We have demonstrated that there may be competition for lipid rafts between repair 
and BCR activation, as both events interfere with one another. Cross-linking BCRs 
decreased CTB internalization and repair. BCR activation not only decreased CTB 
internalization overall, but it also decreased CTB internalization into tubular vesicles. 
This suggests that BCR activation modulates lipid raft surface distribution, which 
prevents the availability of rafts for endocytosis and repair.  
 B cells require lipid rafts for BCR clustering, BCR signaling, and 
antigen internalization (85, 93, 164, 165). Membrane wounding decreased BCR 
capping and co-capping with lipid rafts. BCR signaling and antigen internalization 
were also decreased significantly. These results imply that membrane damage by 
SLO prevents BCRs from entering lipid rafts and thus inhibits overall B cell 
activation. This is a new finding and demonstrates that membrane injury and repair 
disrupts lipid rafts that are important for surface receptor signaling. These findings 
correlate with how the Epstein Barr Virus (EBV) inhibits BCR signaling and 




(LMP2A). LMP2A has a binding site for Lyn, which enables it to reside within lipid 
rafts and exclude BCRs, which prevents BCRs from entering the lipid rafts to signal 
and internalize antigen (165, 166). 
 
 Further investigation of the competition for lipid raft, we examined 
internalization of CTB in relation to BCR. Activation of BCRs induces co-
localization of lipid rafts with BCR on the cell surface and internalization together 
into the same vesicles (164). SLO treatment decreased this co-localization and the 
separation of BCRs from CTB started as early as 1 min on the cell surface. The 
increase of internalization into separate compartments strongly suggests that there is 
competition for lipid rafts.  
 Membrane repair inhibits B cell activation by competing for the same lipid 
rafts, which decreases the amount of raft available for BCR clustering, BCR 
signaling, and antigen internalization. The impact this has on later stages of B cell 
activation and immunological functions requires investigation. There are several 
possible outcomes for repaired B cells. They could recover completely and regain 
functions for BCR clustering, signaling, and antigen internalization. Or repaired B 
cells may lose the ability to become activated and are prevented from presenting 
antigen to T helper cells, thus blocking development into plasma cells and memory B 
cells. Another possibility is for the repaired B cell to become inert and function to 
present antigen to other B cells. We have shown that SLO treatment decreases antigen 
internalization, which means the antigen will remain on the B cell’s surface and is 




group A streptococcus (GAS) induces keratinocyte lysosomal exocytosis to sites of 
plasma membrane not localized with the GAS, this then inhibits uptake of the bacteria 
(213). Although this is a strategy used by bacteria to avoid internalization and 
destruction, in the case of B cells, which are small motile cells, they may migrate to 
present the bacteria to other B cells.   
 
 
B cell membrane damage in vivo 
Although we have not demonstrated that B cells have their membranes damaged in 
vivo, there exists many possibilities for membrane wounding. B cells may have their 
membranes damaged by bacterial toxins or mechanically injured during migration or 
by other cell-cell interactions. Lymphocytes extravasate, migrating through 
endothelial cells to reach infected sites and they also migrate through dense and well-
organized lymphoid tissues. Squeezing through these tight spaces is liable to tear 
membranes. Activated B cells may transfer portions of their plasma membrane along 
with BCRs to bystander B cells through close cell-cell contact (170). Also B cells 
serve as APCs and T cells and B cells are able to remove membrane from APCs while 
extracting antigen (84, 125). When B cells enter infected sites, they are likely to come 
in contact with bacteria and bacterial toxins. There are approximately thirty bacterial 
species that produce pore forming toxins and many of the pore-forming toxins are 
cholesterol dependent cytolysins (126, 127).  
 We have shown that SLO treatment inhibits B cell activation; this may 




determine how and where B cells are damaged and what implications this may have 
for immunity and disease. 
 
Properties of antigen and B cell activation 
Increasing the valency or concentration of soluble antigen enhances B cell activation 
(25, 80, 116). We sought to determine whether this is the case for membrane-bound 
antigen, since the majority of antigens in vivo are presented to B cells as membrane 
bound (23).  Previous studies have shown that increasing the density of membrane 
bound antigen enhances B cell spreading and antigen accumulation (64), however, the 
current membrane bound antigen systems do not present monovalent antigen that is 
correctly oriented for directly binding BCRs. We established and characterized a 
membrane-bound antigen system where all antigenic molecules are optimally 
orientated for BCR binding. Using both Fab’ and HEL, we generated antigens that 
were shown to be monovalent and monobiotinylted, thus obtaining optimal 
orientation when added to streptavidin coated biotinylated lipid bilayers.  
Using these optimally oriented systems, we determined the role of the density 
and valancy of membrane-bound antigen on BCR activation. The results show that 
increases in the density, but not valency of antigen on membranes significantly 
enhance the magnitudes of the early events of BCR activation. Increasing antigen 
density proportionally increases B cell spreading, BCR clustering, and BCR 
signaling. Live imaging of LifeAct B cells, demonstrated that higher antigen densities 
enhanced actin dynamics, which corresponds to greater B cell spreading and BCR 




edges of the spreading membrane and then forms a ring around the antigen to form 
the synapse (61, 73), this was also seen, and we further demonstrated the role of 
antigen density on actin intensity and distribution. Low antigen density induced 
decreased actin dynamics, inhibiting B cell spreading and BCR clustering. Increasing 
antigen density enhanced actin intensities at the edges of the spreading membrane and 
this in turn related to greater B cell spreading and BCR clustering. These results 
coincide with previous studies showing increasing densities of membrane antigen 
enhances B cell spreading and antigen accumulation. Our work further demonstrates 
that the increase in B cell activation is proportional to the increase in antigen density 
and this enhanced activation is correlated with greater actin dynamics required for 
BCR aggregation, B-cell spreading and signaling. 
In contrast to antigen density, valency had no effect on B cell spreading, 
antigen accumulation, or BCR signaling. This data supports the finding that 
monovalent membrane bound antigen still induces B cell activation due to the 
induced conformational change in the BCR, which initiates BCR oligomerization 
(68). Thus when presented on membranes, the valency of an antigen has little effect 
on increasing BCR clustering and initiating signaling and spreading.   
Our work suggests that density of membrane bound antigen rather then 
valency is crucial for activating B cells. Also the orientation of antigen is important, 
as presentation of the same epitope at high density induces enhanced B-cell 
activation. The exact density of membrane bound antigen required for efficient B-cell 
activation has not been determined, but we designed a system where this is possible 




underlying BCR activation. The results here indicate that manipulations of an 
antigen’s molecular configuration and density can be applied to enhance the 
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